Page last updated: 2024-08-21

vancomycin and Recrudescence

vancomycin has been researched along with Recrudescence in 349 studies

Research

Studies (349)

TimeframeStudies, this research(%)All Research%
pre-199041 (11.75)18.7374
1990's43 (12.32)18.2507
2000's69 (19.77)29.6817
2010's159 (45.56)24.3611
2020's37 (10.60)2.80

Authors

AuthorsStudies
Blake, S; Hixon, MS; Janda, KD; Lin, M; Rivera, AJ; Thanissery, R; Theriot, CM1
Allerberger, F; Bouza, E; Burns, K; Coia, JE; Fitzpatrick, F; Goorhuis, A; Guery, B; Hristea, A; Krutova, M; Kuijper, EJ; Norén, T; Ooijevaar, RE; Reigadas, E; Scharvik Olesen, BR; Tschudin-Sutter, S; van Prehn, J; van Rossen, TM; Vehreschild, MJGT; Vogelzang, EH; Wilcox, MH1
Bazazhina, A; Najjar-Debbiny, R; Saliba, W; Schwartz, N; Shaked, P; Weber, G1
Calais, LA; Climo, MW; Donskey, CJ; Ge, L; Gerding, DN; Goetz, MB; Goldberg, AM; Gordin, FM; Gupta, K; Haegerich, T; Johnson, M; Johnson, N; Johnson, S; Li, X; Reda, DJ; Ringer, R1
Armiñanzas Castillo, C; Cano Yuste, A; Cobo Reinoso, J; De La Torre Cisneros, J; Díaz Pollán, B; Escudero-Sanchez, R; Fernández Fradejas, J; García Basas, L; García Fernández, S; Giner, L; Gutierrez Rojas, A; Gutiérrez, B; López Medrano, F; Martín Segarra, O; Merino De Lucas, E; Muriel García, A; Olmedo Sampedrio, M; Ramos Martínez, A; Rodríguez Hernández, MJ; Rodríguez-Pardo, D; Ruíz Ruigomez, M; Sáez Bejar, C; Salavert Lletí, M; Tasias Pitarch, M; Valencia Alijo, A1
Aftandilian, CC; Agyeman, PKA; Castagnola, E; Chirra, KM; Dupuis, LL; Groll, AH; Haeusler, GM; Lehrnbecher, T; Loves, R; Phillips, B; Schneider, C; Sung, L; van de Wetering, M1
Budi, ND; Godfrey, JJ; Rose, WE; Safdar, N; Shukla, SK1
Chen, Y; Gu, S; Li, L; Lv, L; Quan, J; Wu, Z; Xu, Q; Zhang, S; Zheng, B1
Appaneal, HJ; LaPlante, KL; Liao, JX; Vicent, ML; Vyas, A1
Allegretti, J; Chang, LL; Dubberke, ER; Skinner, AM1
Farraye, FA; Hashash, JG; Khanna, S; Koop, AH; Pardi, DS; Travers, PM1
Bi, Z; Chen, C; Hamilton, MJ; Khoruts, A; Roy, S; Sadowsky, MJ; Su, R; Zhang, L; Zhou, Y1
Cacace, J; Goldman, DL; Lee, P; Nemati, K; Silver, EJ1
Chow, A; Lye, DC; Ng, TM; Tay, HL1
English, M; Fukushima, A; Okumura, H; Shoji, S; Taieb, V1
Gasbarrini, A; Gisbert, JP; Hold, GL; Malfertheiner, P; Megraud, F; O'Morain, C; Rokkas, T; Tilg, H1
Allegretti, JR; Bry, L; Gerber, GK; Kennedy, K; Marcus, J; Sitko, J; Storm, M1
Atamna, A; Avni, T; Ayada, G; Babitch, T; Ben-Zvi, H; Bishara, J; Hijazi, R1
Andersen, M; Lei, DK; Ollech, JE; Rubin, DT; Sossenheimer, P; Weisshof, R; Zmeter, N1
Chen, YX; Li, HY; Li, L; Liu, C; Lv, PP; Wang, Y; You, JX; Zhao, F; Zhu, WF1
Chan, PKS; Jiang, X; Lee, WH; Ng, SC; You, JHS1
Gandhi, TN; Malani, PN1
Kimura, T; Stanhope, S; Sugitani, T1
English, M; Okumura, H; Shoji, S; Ueyama, M1
Abutaleb, NS; Seleem, MN1
Atalla, E; Mylonakis, E1
Gao, L; Li, Y; Liu, G1
Bickett-Burkhart, K; Chalasani, N; Fischer, M; Gandhi, D; Orman, ES; Phatharacharukul, P; Purpura, RD; Xu, H1
Alrahmany, D; El Nekidy, WS; Ereshefsky, BJ; Ghazi, IM; Pontiggia, L1
Gutin, LS; Lam, AY; Nguyen, Y; Velayos, FS1
Bernstein, CN; Kao, D; Lee, C; Rubin, DT; Shaffer, SR; Singh, H; Smieliauskas, F; Targownik, LE; Witt, J1
Benes, J; Capek, V; Krutova, M; Polivkova, S; Sykorova, B1
Abad, D; Alfaro, E; Cañamares, P; García, S; Hernández, M; Hijos, G; Laredo, V; Lorente, S; Saura, N; Velamazán, R1
Campbell, DL; Gentry, CA; Williams, RJ1
Coe, K; Reed, EE; Rinaldi, A; Smith, JM; Stevenson, KB1
Bidell, MR; Bratek, BR; Duru, OO; Mitchell, CL; Novak, GM; O'Donnell, JN; Roddy, KM; Singh, G1
Andersen, CØ; Bytzer, P; Chehri, M; Engberg, J; Helms, M; Heno, KK; Jensen, US; Krogsgaard, LR; Petersen, AM; Ribberholt, I; Rode, AA; Schønning, K; Svendsen, AT; Tvede, M1
Chiu, CW; Hung, YP; Ko, WC; Lee, CC; Tsai, PJ1
Shin, JH; Warren, CA1
Cao, L; Guo, W; Ji, B; Mu, W; Xu, B; Zhang, X1
Alcalá, L; Bouza, E; de Egea, V; González-Del Vecchio, M; Marín, M; Muñoz, P; Reigadas, E; Valerio, M1
Axelrad, JE; Green, PHR; Joelson, A; Lawlor, G; Lebwohl, B; Lichtiger, S; Nobel, YR1
Bryan, M; Gerber, JS; Hamdy, RF; Hersh, AL; Hsu, AJ; Olson, JA; Stockmann, C; Tamma, PD1
Allen, S; DiBaise, JK; Griesbach, CL; Hartmann, CA; Kosiorek, HE; Orenstein, R; Patron, RL1
Bachmann, O; Dersch, P; Solbach, P1
Gerding, DN; Johnson, S; Lum, J; Manzo, C; Sirbu, BD; Soriano, MM1
Leidi, F; Wu, MA1
Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP1
Eckmann, L; Fuhrmann, V; Manthey, CF1
Blanco, N; Eisenberg, MC; Foxman, B; Malani, AN; Rickard, AH; Walk, S; Zhang, M1
Carignan, A; Couture-Cossette, A; Ilangumaran, S; Valiquette, L1
Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C1
Descourouez, JL; Jorgenson, MR; Kerstenetzky, L; Leverson, GE; Redfield, RR; Saddler, CM; Safdar, N; Smith, JA; Splinter, LE1
Iguchi, M; Kuzuya, T; Mikamo, H; Morioka, H; Yagi, T1
Burton, HE; Mitchell, SA; Watt, M1
Gow, P; Hey, P; Johnson, P; Lokan, J1
Aoyama, N; Dorr, MB; Fujimoto, G; Mikamo, H; Sawata, M; Yoshinari, T1
Cossrow, N; Dorr, MB; Dubberke, ER; Elbasha, E; Jiang, Y; Marcella, S; Prabhu, VS1
Kupiec, KE; Liu, C; Miller, JL; Schmidt, SA; Skrepnek, GH; Smith, WJ; Tieu, JD1
Jamot, S; Kelly, CR; Lim, SH; Patel, K; Raghunathan, V1
Amat, C; Carrera, L; Corona, PS; Lalanza, M; Vicente, M1
Aderman, CM; Bhisitkul, RB; Chao, DL; Chiu, CS; Obeid, A; Schwartz, DM1
Abe, K; Furukawa, K; Ishida, Y; Sakamoto, T; Shiba, H; Yanaga, K1
Anders, S; Garcia-Diaz, J; Hand, J; Li, J; Nguyen, CT; Staffeld-Coit, C1
Goyal, H; Perisetti, A; Rehman, MR; Singla, U1
Dorr, MB; Dubberke, ER; Ellison, MC; Eves, K; Gerding, DN; Guris, D; Hanson, ME; Kao, D; Kelly, CP; Kumar, PN; Lee, C; Rahav, G; Yacyshyn, B1
Alarcon Velasco, SV; Mbaebie, NC; Touhey, J1
Cornely, OA; De Nigris, E; Goldenberg, SD; McCrea, C; Watt, M1
Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G1
Archuleta, S; Chan, YFZ; Kalimuddin, S; Low, JGH; Lye, DC; Ong, SP; Phillips, R; Tan, TT1
Barbosa, KVBD; Chebli, JMF; Chebli, LA; Costa, LA; da Rocha Ribeiro, TC; de Almeida Cruz, W; de Assis, IC; de Lima Pace, FH; Gaburri, PD; Garcia, PG; Moraes, BRM; Zanini, A1
Gamo, K; Hashimoto, A; Kato, K; Kusachi, S; Mikamo, H; Miki, T; Oizumi, Y; Takesue, Y; Tateda, K; Toyoshima, J; Yanagihara, K1
Chalfin, DB; Delgado, D; Fraser, TG; Lam, SW; Neuner, EA1
Enoki, Y; Igarashi, Y; Kunishima, H; Matsumoto, K; Mikamo, H; Mori, N; Morinaga, Y; Nakamura, A; Ohge, H; Suzuki, H; Taguchi, K; Tashiro, S; Yamagishi, Y; Yanagihara, K; Yoshizawa, S1
Cifu, AS; Gupta, A; Khanna, S1
Fleming, ME; Gordon, WT; Jessie, EM; Khan, M; Malone, DL; Murray, CK; Potter, BK; Rodriguez, CJ; Shackelford, SA; Tribble, DR1
Gandhi, S; Patel, D; Sohal, S1
Cho, S; Dubinsky, MC; Grinspan, A; Hirten, R; Spencer, E1
Gentry, CA; Skrepnek, GH; Tieu, JD; Williams, RJ1
Gentry, CA; Kurdgelashvili, G; Nguyen, PK; Skrepnek, GH; Thind, S; Williams, RJ1
Dahl Jørgensen, SM; Dahlerup, JF; Erikstrup, C; Hansen, MM; Hvas, CL; Jørgensen, SP; Lemming, L; Storgaard, M1
Abouanaser, S; Beckett, P; Lee, C; Smieja, M; Stankus, V; Zhang, K1
Boyanova, L; Hadzhiyski, P; Markovska, R; Mitov, I; Yaneva, P; Yordanov, D1
Alowami, S; Chin-Yee, B; El-Helou, P; Gangji, A; Lee, S; Lo, CK; Ribic, C; Wang, MK1
Adomakoh, N; Cornely, OA; Georgopali, A; Guery, B; Karas, A; Kazeem, G; Vehreschild, MJGT1
Lee, SJ; Lee, SU; Nam, KY; Noh, GM; Park, ID1
Kimura, T; Snijder, R; Sugitani, T1
Calderwood, MS; Caroff, DA; Klompas, M; Kubiak, DW; Menchaca, JT; Rhee, C; Yokoe, DS; Zhang, Z1
Berthiller, J; Chardot, C; Duclaux-Loras, R; Ferroni, A; Goulet, O; Lacaille, F; Norsa, L1
Bryson-Cahn, C; Chan, JD; Jain, R; Liu, C; Lynch, JB1
Baines, SD; Camacho-Ortíz, A; Flores-Treviño, S; Garza-González, E; Maldonado-Garza, H; Morfín-Otero, R; Rodríguez-Noriega, E; Tijerina-Rodríguez, L; Villarreal-Treviño, L1
Horbal, J; Hostoffer, R; Jhaveri, D; Marino, J; Sterbank, J; Tcheurekdijian, H; Tcheurekdjian, H1
Chan, JY; Elliott, AJ; Ellis, SJ1
Eisenbach, C; Mischnik, A; Sandig, C; Steinebrunner, N; Stremmel, W; Zimmermann, S1
Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E1
Bass, SN; Bauer, SR; Lam, SW; Neuner, EA1
Ebigbo, A; Messmann, H1
John, E; Lippmann, N; Lübbert, C; Mössner, J; Weis, S1
Barro, V; Cáceres, E; Corona, PS; Flores, X; Mendez, M1
Aires, D; Jibbe, A; Liu, D; Tefft, K; Weir, G1
Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N1
Collins, SH; D'Agostino, RB; Gorbach, S; Kean, Y; Pencina, KM1
Chow, KM; Kwan, BC; Lee, KP; Leung, CB; Li, PK; Ma, TK; Szeto, CC1
Broom, C; Chasan-Taber, S; Cornely, OA; Davidson, DM; Fitts, D; Gelone, SP; Gerding, DN; Johnson, S; Louie, TJ1
Cosler, L; Drusano, GL; El-Fawal, N; Evans, A; Graffunder, E; Jones, RN; Lazariu, V; Lodise, TP; McNutt, LA; Mendes, RE; Stellrecht, K1
Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M1
Aitken, SL; DuPont, HL; Garey, KW; Joseph, TB; Lasco, TM; Palmer, HR; Shah, DN; Xie, Y1
Chen, Z; Cheng, H; Deng, QW; Pan, WG; Yang, WZ; Yu, ZJ; Zheng, JX1
Díaz-Domínguez, M; Quereda-Rodríguez-Navarro, C; Rivera-Gorrin, M; Rodríguez-Mendiola, N; Ruiz-Roso, G; Teruel-Briones, JL1
Dees, A; Jonkman, JG; van Genderen, ME; van Rijn, M1
Johnson, S; Soriano, MM1
Keller, JJ; Kuijper, EJ1
Payne, L; Sattar, A; Thommes, P; Vickers, RJ; Warn, P1
Christenson, ES; Hsu, S; Ligon, C1
Dubberke, ER; Olsen, MA; Reske, KA; Yan, Y; Zilberberg, M1
Liu, W; Lv, Z; Peng, G; Su, J; Xu, H1
Alm, E; Burgess, J; Burns, L; Didyk, E; Edelstein, C; Giovanelli, A; Kassam, Z; Mendolia, G; Noh, A; Smith, M; Stollman, N1
Ananthakrishnan, AN; Barber, GE; Wen, J1
Chilton, CH; Crowther, GS; Freeman, J; Nicholson, S; Todhunter, SL; Wilcox, MH1
Carreiro, FT; Coelho, SC; Horta, AB; Sá, J1
Cury, JD; Dakkak, M; Siddiqi, F1
Vaishnavi, C1
Marra, F; Ng, K1
Acuña, G; Moscoso, F; Quera, R; Rivera, D; Simian, D1
Doron, S; Gorbach, S; Mizusawa, M1
Buitrago, M; Charef, P; Cornely, OA; Gerding, DN; Kracker, H; Louie, T; Nord, CE; Talbot, GH; Wilcox, M1
Greenberg, A; Matta, SK; Singh, A1
Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A1
Jacobson, SM; Slain, D1
Abou Chakra, CN; Marcil-Héguy, A; Nault, V; Pépin, J; Sheitoyan-Pesant, C; Valiquette, L1
Adamson, R; Bauer, K; Bensman, J; Chaudhry, SB; Culshaw, DL; Eskandarian, R; Goff, DA; Lamp, KC; Leuthner, K; Lodise, T; McKinnell, JA; Moise, PA; Reyes, K; Smith, WJ; Virata, MD; Wong-Beringer, A; Zervos, MJ1
Chilton, CH; Crowther, GS; Ewin, D; Karas, A; Longshaw, C; Todhunter, SL; Vernon, J; Wilcox, MH1
Almeida, DR; Chin, EK; Mahajan, VB1
Han, WD; Kang, YM; Kim, ES; Kim, HB; Kim, NH; Kim, NJ; Lee, DG; Oh, MD; Park, C; Park, KH; Park, KU; Park, SW; Song, KH; Yoo, JI1
Brain, D; Connelly, LB; Graves, N; Merlo, G1
Baloun, B; Gilbert, J; Nelson, C; Wiedel, N1
Beneš, J; Polívková, S1
Cantón, R; Del Campo, R; Fortun, J; Morosini, MI; Ponce-Alonso, M1
Brodsky, D; Halevi, CN; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L1
Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B1
Telekes, A1
Chesnel, L; Lee, CH; Louie, T; Mullane, KM; Patino, H; Rege, S; Stevens, C1
Dezsenyi, B; Fried, K; Gergely Szabo, B; Kadar, B; Kamotsay, K; Kunovszki, P; Nikolova, R; Prinz, G; Szidonia Lenart, K1
Al-Bachari, H; Carignan, A; Labbé, AC; Martin, P; Montpetit, LP; Pépin, J; Poulin, S; Valiquette, L1
Boccuzzi, E; Borali, E; Castellazzi, L; Cursi, L; De Giacomo, C; De Vita, MV; Esposito, S; Garazzino, S; Guarino, A; Lancella, L; Lo Vecchio, A; Mainetti, M; Tagliabue, C1
Kim, SH; Lee, J; Yoo, RN1
Fashandi, AZ; Friel, CM; Hallowell, PT; Hays, RA; Hedrick, TL; Martin, AN; Smith, PW; Wang, PT1
Coburn, B; Guttman, DS; Hota, SS; Low, DE; McGeer, A; Poutanen, SM; Sales, V; Salpeter, MJ; Tomlinson, G1
Baro, E; Denies, F; Dervaux, B; Galperine, T; Guery, B; Lannoy, D; Lenne, X; Odou, P1
Dinh, A; Le Monnier, A; Tilleul, P; Watt, M1
Brewer, J; Bulchandani, D; Fitzsimmons, C; Jost, P; Nachnani, J1
Baratz, M; Ehrlich, GD; Gahlot, V; Johnson, S; Kathju, S; Lasko, LA; Nistico, L; Stoodley, P1
Bartelsman, JF; Jansen, JM; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; van Heukelem, HA; van Nood, E; Visser, CE1
Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T1
Camplese, P; Iarussi, T; Marolla, A; Pardolesi, A; Patea, RL; Sacco, R1
Balázs, G; Ivády, B; Liptai, Z; Ujhelyi, E1
Castagnini, LA; DiCaprio, HS; Julapalli, MR; Peña, JA; Phelps, BR; Pirics, ML; Tolle, MA1
Bujanda, L; Cosme, A1
Kelly, CP2
Altman, A; Paz, Z1
Johnson, S1
Dang, S; Davies, D; Sigal, Y1
Chow, KM; Chung, KY; Kwan, BC; Law, MC; Leung, CB; Li, PK; Pang, WF; Szeto, CC1
Candinas, D; Inderbitzin, D; Keller, M; Keogh, A; Mennicke, M; Pichler, WJ; Stickel, F; Wilkens, L; Yawalkar, N; Zawodniak, A1
Schlaudecker, JD1
Fisher, S; Levy, I; Livni, G; Megged, O; Shalit, I; Yaniv, I1
Scheppach, W1
Aas, J; Gessert, CE; Rubin, TA1
Bozic, KJ; Kalra, KP; Lin, KK; Ries, MD1
Grajek, S; Ozorowski, T; Straburzyńska-Migaj, E; Trojnarska, O; Łanocha, M1
Banaszkiewicz, A; Brazier, JS; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; van Belkum, A; Wultańska, D1
Jeong, JB; Jung, HC; Kim, BG; Kim, JS; Kim, JW; Lee, KL; Shin, S; Song, IS1
Salkind, AR1
Balne, PK; Bhatia, K; Mathai, A; Reddy, AK; Reddy, BV; Sambhav, K1
Bargman, JM; Heywood, A1
Alexander, J; Surawicz, CM1
Misawa, Y; Morita, H; Oki, S; Saito, T1
Choi, HK; Kim, KH; Lee, SH; Lee, SJ1
Abbott, AN; Armitige, LY; Gardiner, JM; Kruzel, MC; Lewis, CT; Lewis, EM; Mohr, JF; Skrobarcek, KA; Wanger, A; Welsh, KJ1
Amundson, WH; Decarolis, DD; Drekonja, DM; Johnson, JR; Kuskowski, MA; Lederle, FA1
LaZear, R; Nayfeh, TA; Roy, ME; Whiteside, LA1
Gardner, E; Mancuso, P; Meghani, N; Thomson, A1
Eskandarian, R; Jobson, S; Moise, PA1
Kang, JO; Kim, J; Pai, H; Seo, MR1
Baban, TA; El-Herte, RI; Kanj, SS1
Jahamy, H; Johnson, LB; Khatib, R; Patel, SM; Riederer, K; Shemes, SP; Szpunar, S; Valenti, S; Venugopal, AA1
Bernard, L; Buzzi, M; Ferry, T; François, P; Harbarth, S; Huggler, E; Lew, DP; Renzoni, A; Schrenzel, J; Uçkay, I; Vaudaux, P1
Bliss, D; Butler, M; Drekonja, DM; Filice, GA; MacDonald, R; Rector, TS; Wilt, TJ1
Barretti, P; Caramori, JC; Cunha, Mde L; Luengo, J; Montelli, AC; Oliveira, LG1
Falagas, ME; Patouni, K; Polyzos, KA; Rafailidis, PI; Samonis, G; Vardakas, KZ1
Aroniadis, OC; Brandt, LJ; Kanatzar, A; Kelly, C; Mellow, M; Park, T; Rohlke, F; Stollman, N; Surawicz, C1
Babakhani, F; Cheknis, A; Gerding, DN; Johnson, S; Kean, Y; Nagaro, K; Petrella, LA; Sambol, SP; Sears, PS1
Armbruster, S; Goldkind, L1
Lamarche, MJ; Leeds, JA; McKenney, D; Praestgaard, J; Trzasko, A1
Cheema, FH; Kanwal, S; Korsten, MA; Luthra, M; Majeed, UM; Rafiullah, F; Sohail, MR1
Barber, N; Franklin, BD; Shebl, NA1
Finnegan, PM; Linneman, TW; McDonald, JR; Moenster, RP1
Babakhani, F; Citron, DM; Goldstein, EJ1
Bauer, MP; Dale, AP; Fawley, WN; Gerding, DN; Gorbach, SL; Hensgens, MP; Kuijper, EJ; Miller, MA; Wilcox, MH1
Carchman, EH; Nassour, I; Simmons, RL; Zuckerbraun, BS1
Kim, SW1
Gerding, DN; Johnson, S1
Abdelghany, O; Ruggero, MA; Topal, JE1
Anttila, VJ; Arkkila, P; Mattila, E; Mattila, PS; Tarkka, E; Tissari, P1
Ha, D; Tsai, CJ1
Cornely, OA1
Brandt, C; Clare, S; Clark, TG; Connor, TR; Deakin, LJ; Dougan, G; Duncan, SH; Flint, HJ; Goulding, D; Lawley, TD; Parkhill, J; Pickard, DJ; Rad, R; Raisen, C; Schreiber, F; Stares, MD; Walker, AW1
Guerrant, RL; Hoffman, PS; Kolling, GL; Li, Y; Moore, JH; Riggins, MS; van Opstal, EJ; Warren, CA1
Barshes, NR; Bechara, CF; Darouiche, RO; Kougias, P; Lin, PH; Pisimisis, G; Poi, MJ1
Bartelsman, JF; de Vos, WM; Dijkgraaf, MG; Fuentes, S; Keller, JJ; Kuijper, EJ; Nieuwdorp, M; Speelman, P; Tijssen, JG; van Nood, E; Visser, CE; Vrieze, A; Zoetendal, EG1
Li, Y; Qian, J; Queener, E; Shen, B1
Elmer, GW; McFarland, LV; Surawicz, CM1
Chiang, RK; Rapuano, CJ1
Hesse, Y; Lang, GK; Spraul, CW1
Alcázar Montero, MS; Gimeno Aranguez, M; Navarro Gaspar, C; Vilalta Castel, E1
Lenzen-Grossimlinghaus, R; Strohmeyer, G1
Hoaglund, PA; Shoultz, DA; Tice, AD1
Federman, DG; Kravetz, JD1
Martirosian, G; Szczesny, A1
Domínguez, I; García Serrano, JL; Serrano Laborda, D1
Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS1
Baker, SD; Horger, DC; Keane, TE1
Oldfield, EC1
Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM1
Au Eong, KG; Chee, CK; Lee, JJ; Teoh, SC1
Gerding, DN1
Alary, ME; Bourassa, C; Fulop, K; Godin, D; Pepin, J; Raiche, E; Ruel, J; Valiquette, L1
Giladi, M; Orni-Wasserlauf, R; Reich, P; Schwartz, D; Siegman-Igra, Y1
Altaş, K; Bağdatli, Y; Bahar, H; Demirci, M; Hiramatsu, K; Kapi, M; Kocazeybek, B; Torun, MM1
Bac, DJ; Dingemans-Dumas, AM; Visser, WE1
Corne, P; Jonquet, O; Macia, JC; Marchandin, H1
Cabrera, D1
Ichinose, Y; Kakeji, Y; Maehara, Y; Yamaguchi, M; Yoshino, I1
Cohen, RA; Eliopoulos, GM; Gold, HS; Moellering, RC; Sakoulas, G; Venkataraman, L1
Lin, SF; Yang, WC1
Hart, WJ; Jones, RS1
Bhavani, SS; Pettersson, GB; Rehm, SJ; Slisatkorn, W1
Cicogna, CE; Kuyumjian, AG; Surowiec, D; Wynd, MA1
Chen, YH; Dickerman, RD; Kattner, KA; Noel, J; Seibly, JM; Stevens, QE1
Heins, JR1
Hornillos Calvo, M; Pareja Sierra, T1
Pakyz, A1
Das, A; Ge, Y; Talbot, GH; Thye, D1
Nazarko, L1
Brazeau, I; Gagnon, S; Pépin, J; Routhier, S; Valiquette, L1
Arnell, K; Enblad, P; Sjölin, J; Wester, T1
Shen, EP; Surawicz, CM1
Al-Nammari, SS; Lam, KS; Lucas, JD1
Gerding, DN; Muto, CA; Owens, RC1
McCracken, GH; Mohs, E; Nelson, JD; Odio, C; Sklar, FH1
Bartlett, JG1
Burdon, DW1
Baer, M; Grönroos, P; Mäki, M; Vesikari, T1
Bartlett, JG; Chang, T; Lowe, B; Shull, S; Tedesco, FJ1
Tedesco, FJ1
LaMont, JT; Trnka, YM1
Meuwissen, SG; Mulder, CJ; Reiss, M; Rietra, PJ; Van Leeuwen, AM; Visser, J1
Rampling, A; Swayne, RL; Warren, RE1
Bartlett, JG; Moskovitz, M1
Murray, D; Portnoy, D; Richards, GK; Soneji, A1
Baird, I; Batts, DH; Fekety, R; Plouffe, JF; Rifkin, GD; Silva, J1
Bartlett, JG; Chang, TW; Gorbach, SL; Saginur, R1
Moore, B; Philpot, CR; Rich, G; Wilkinson, IJ1
Bowman, RA; Riley, TV1
Roberts, RK; Seneviratne, E1
Rampling, A; Sykes, HV; Warren, RE1
Chan, SM; Chia, JK; Goldstein, H1
Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shea, MH1
Caron, F; Gutmann, L; Humbert, G; Kitzis, MD; Lemeland, JF; Pestel, M1
Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA1
Messick, CR; Reinke, CM1
Andremont, A; Boasson, M; Cordonnier, C; Herbrecht, R; Kazmierczak, A; Leverger, G; Marie, JP; Marit, G; Miclea, JM; Schlemmer, B1
Hoppen, T; Keller, KM; Rister, M; Stolte, M1
García, D; Javaloyas, M; Ruffi, G1
Henrickson, KJ; Sheth, KJ1
Klaus, G; Mehls, O; Müller-Wiefel, D; Schaefer, F1
Bacino, A; Bonatti, L; Borello, G; Galliano, R; Lorenzini, L; Marchesa, P; Massaioli, N1
Aljundi, H; Held, M; Khatib, R; Riederer, KM1
Schweitzer, MA; Silver, DL; Stellato, TA; Sweiss, I1
Graninger, W; Hasenhündl, M; Hirschl, AM; Parschalk, B; Wenisch, C1
Brown, CW; Chow, GH; Gebhard, JS1
Fujita, K; Kato, H; Kato, N; Sakata, Y; Ueno, K; Watanabe, K1
Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Mulligan, ME; Surawicz, CM1
Johnson, JA; Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R1
Casewell, MW; Rolando, N; Wade, JJ; Williams, R1
Piraino, B1
Kelly, CP; LaMont, JT1
Ayyala, RS; Fouraker, BD; Grizzard, WS; Stevens, SX1
Hargrave, J; Roberts, RB; Serur, D; Sieradzki, K; Tomasz, A2
Aziz, NS; Gendeh, BS; Gibb, AG; Kong, N; Zahir, ZM1
Dan'ura, T; Inoue, H; Kunisada, T; Naito, N; Ozaki, T; Yoshitaka, T1
Corpuz, M; Nair, S; Pitchumoni, CS; Yadav, D1
Elmer, GW; Fekety, R; Greenberg, RN; McFarland, LV; Rubin, M; Surawicz, CM1
Alvarez-Grande, J; Baltar, J; Díaz-Corte, C; Gago, E; Peces, R1
Müller-Wiefel, DE1
Antoine, C; Arfi, C; Desgrippes, A; Fournier, R; Le Duc, A; Martinat, L; Meria, P; Teillac, P1
Danko, L; Elmer, GW; Greenberg, RN; McFarland, LV; Surawicz, CM1
Aldave, AJ; Deramo, VA; Fischer, DH; Maguire, JI; Shah, GK; Stein, JD1
English, BK; McCullers, JA; Novak, R1
Chen, JC; Roy, M1
Alcantara, CS; Guerrant, RL1
Borjal, D; Bowen, K; Brandmarker, S; Elmer, GW; Fekety, R; Garcia, RJ; Greenberg, RN; McFarland, LV; Mulligan, ME; Rubin, M; Surawicz, CM1
Ballmer, PE; Bergamin, B; Hess, T; Imoberdorf, R; Jost, R1
Duch, JM; Yee, J1
Kurup, A; Lin, R; Loo, LH; Tee, WS1
Aihara, M; Chiba, T; Hajiro, K; Nishi, A; Sakurai, T; Takakuwa, H1
Ahmad, A; Dick, D; Hullin, MG; Skinner, GR; Zafar, A1
Kelly, CP; Kyne, L1
Chang, JD; Cho, SH; Ha, YC; Kim, SY; Kim, YH; Koo, KH; Park, HB; Song, HR; Yang, JW1
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA1
Handke, R; Schmitt-Grohé, S; Steffan, J; Wiggert, E; Zielen, S1
Bae, GB; Kang, HR; Kang, YM; Kim, JH; Kim, NS; Kim, SW; Lee, JM; Nam, EJ; Park, JH1
Finch, RG; George, RH; Lewis, MJ; Slack, RC; Thomas, HJ1
Karchmer, AW; Maki, DG; Moellering, RC; Swartz, MN1
Finegold, SM; George, WL; Liechty, EJ; Mok, HY; Richman, DD; Rolfe, RD; Stiner, DB; Volpicelli, NA1
Spencer, RC; Wilcox, MH1
Anwar, N; Gokal, R; Merchant, MR; Tooth, JA; Uttley, L; Were, A1
Klaus, G; Mehls, O; Querfeld, U; Schäfer, F; Soergel, M; Wolf, S1
Huang, SC; Kuo, MF; Wang, HS1
Dru, M1
Lam, TY; Oreopoulos, DG; Vas, SI1
Haimann, MH; Miller, JA; Weiss, H1
Brandi, L; Ejlersen, E; Haarh, P; Kopp, R; Ladefoged, J; Løkkegaard, H1
Flanigan, MJ; Lim, VS1
Chambers, HF; Small, PM1
Boletis, I; Brown, CB; Cohen, GL; el Nahas, AM; Johnson, BF; Moorhead, PJ; Raftery, AT; Williams, AJ1
Ackrill, P; Bowley, JA; Burnie, J; Fleming, SJ; Oppenheim, BA; Pickering, SJ; Ralston, AJ; Sissons, P1
Powell, KR; Pruksananonda, P1
Coucudis, P; Jafer, H; Jara, F; Kartali, S; Pasadakis, P; Peihaberis, P; Thodis, H; Vargemezis, V1
Ben-Ezer Gradus, D; Benjamin, J; Chaimovitz, C; Mostoslavski, M; Rapoport, J1
Chinn, J; Elmer, G; McFarland, LV; Surawicz, CM1
Brown, E; Hendler, E1
Ehni, WF; Reller, LB1
Clumeck, N; De Wit, S; Goosens, H; Hermans, P; Van Laethem, Y1
DeBenedictis, TH; Gorecki, GA1
Chambers, HF; Miller, RT; Newman, MD1
Bayley, N; McDonald, MI; St John, DJ; Ward, P; Young, GP1
Carrington, G; Dudley, MN; Frick, J; McLaughlin, JC; Nightingale, CH; Quintiliani, R1
Elmer, GW; McFarland, LV1
Barclay, F; Bonnycastle, M; Borriello, SP; Piper, M; Seal, D; Welch, A1
Buggy, BP; Fekety, R; Silva, J1
Beart, RW; Talbot, RW; Walker, RC1
McDonald, M; Young, G1
Fortson, WC; Gordon, D; Tedesco, FJ1
Vacek, V1

Reviews

52 review(s) available for vancomycin and Recrudescence

ArticleYear
Path of least recurrence: A systematic review and meta-analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection.
    Pharmacotherapy, 2022, Volume: 42, Issue:11

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Middle Aged; Recurrence; Vancomycin

2022
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Metronidazole; Recurrence; Treatment Outcome; Vancomycin

2020
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent
    United European gastroenterology journal, 2019, Volume: 7, Issue:8

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Middle Aged; Network Meta-Analysis; Placebos; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Vancomycin

2019
Inhibition of spores to prevent the recurrence of Clostridioides difficile infection - A possibility or an improbability?
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Development; Fidaxomicin; Recurrence; Secondary Prevention; Spores, Bacterial; Vancomycin

2021
Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.
    Gut microbes, 2017, 09-03, Volume: 8, Issue:5

    Topics: Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Immunologic Factors; Mice; Recurrence; Vancomycin

2017
[Individualized treatment strategies for Clostridium difficile infections].
    Der Internist, 2017, Volume: 58, Issue:7

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Metronidazole; Recurrence; Secondary Prevention; Vancomycin

2017
Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Expert review of clinical pharmacology, 2017, Volume: 10, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Design; Humans; Metronidazole; Practice Guidelines as Topic; Recurrence; Severity of Illness Index; Vancomycin

2017
Bezlotoxumab for the prevention of Clostridium difficile recurrence.
    Expert opinion on biological therapy, 2017, Volume: 17, Issue:11

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Bacterial Proteins; Bacterial Toxins; Broadly Neutralizing Antibodies; Clinical Trials as Topic; Clostridium Infections; Half-Life; Humans; Recurrence; Vancomycin

2017
A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.
    PharmacoEconomics, 2017, Volume: 35, Issue:11

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; Hospitalization; Humans; Metronidazole; Recurrence; Vancomycin

2017
New and emerging therapies in treatment of Clostridium difficile infection.
    European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:6

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin; Vancomycin Resistance

2018
Cost-effectiveness of three different strategies for the treatment of first recurrent Clostridium difficile infection diagnosed in a community setting.
    Infection control and hospital epidemiology, 2018, Volume: 39, Issue:8

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Fidaxomicin; Health Care Costs; Humans; Monte Carlo Method; Quality-Adjusted Life Years; Recurrence; Vancomycin

2018
Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:11

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Metronidazole; Randomized Controlled Trials as Topic; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin

2018
Crusted scabies in a renal transplant recipient treated with daily ivermectin: A case report and literature review.
    Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3

    Topics: Administration, Oral; Aged; Animals; Diagnosis, Differential; Exanthema; Humans; Immunosuppression Therapy; Ivermectin; Kidney Transplantation; Male; Recurrence; Sarcoptes scabiei; Scabies; Sepsis; Skin; Vancomycin

2019
[Clostridium difficile infection: epidemiology, disease burden and therapy].
    Orvosi hetilap, 2013, Jul-28, Volume: 154, Issue:30

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin

2013
Peritoneal-dialysis related peritonitis caused by Gordonia species: report of four cases and literature review.
    Nephrology (Carlton, Vic.), 2014, Volume: 19, Issue:7

    Topics: Actinomycetales Infections; Aged; Anti-Bacterial Agents; Device Removal; Disease Management; Gordonia Bacterium; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Meropenem; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prosthesis-Related Infections; Recurrence; Thienamycins; Treatment Outcome; Vancomycin

2014
Treatment of Clostridium difficile infections.
    Infectious disease clinics of North America, 2015, Volume: 29, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Drug Therapy, Combination; Fidaxomicin; Gastrointestinal Diseases; Humans; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Thiazoles; Vancomycin

2015
Treatment of recurrent and severe Clostridium difficile infection.
    Annual review of medicine, 2015, Volume: 66

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Humans; Metronidazole; Microbiota; Recurrence; Severity of Illness Index; Transplantation; Vancomycin

2015
Fidaxomicin--the new drug for Clostridium difficile infection.
    The Indian journal of medical research, 2015, Volume: 141, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Recurrence; Vancomycin

2015
Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection.
    Drugs, 2015, Volume: 75, Issue:10

    Topics: Aminoglycosides; Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Incidence; Metronidazole; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Probiotics; Recurrence; Risk Factors; Vancomycin

2015
Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Drugs & aging, 2015, Volume: 32, Issue:8

    Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Fidaxomicin; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin

2015
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2

    Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection

2017
[Oncologic aspects of Clostridium difficile].
    Orvosi hetilap, 2016, Volume: 157, Issue:28

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Gastrointestinal Microbiome; Humans; Recurrence; Risk Factors; Vancomycin

2016
[Clostridium-difficile-associated diarrhea].
    Gastroenterologia y hepatologia, 2009, Volume: 32, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin

2009
A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection.
    JAMA, 2009, Mar-04, Volume: 301, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Intestines; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Severity of Illness Index; Vancomycin

2009
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    The Journal of infection, 2009, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin

2009
[Infections with Clostridium difficile following antibiotic therapy].
    MMW Fortschritte der Medizin, 2009, Oct-01, Volume: 151, Issue:40

    Topics: Administration, Oral; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Endoscopy; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Recurrence; Time Factors; Vancomycin

2009
Clostridium difficile: an update for the primary care clinician.
    Southern medical journal, 2010, Volume: 103, Issue:9

    Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin

2010
Treatment of refractory and recurrent Clostridium difficile infection.
    Nature reviews. Gastroenterology & hepatology, 2011, Volume: 8, Issue:6

    Topics: Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin

2011
Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Drug Therapy, Combination; Female; Humans; Metronidazole; Minocycline; Recurrence; Rifamycins; Rifaximin; Tigecycline; Treatment Outcome; Vancomycin

2012
Comparative effectiveness of Clostridium difficile treatments: a systematic review.
    Annals of internal medicine, 2011, Dec-20, Volume: 155, Issue:12

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Comparative Effectiveness Research; Diarrhea; Drug Therapy, Combination; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin

2011
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:1

    Topics: Anti-Bacterial Agents; Asia; Clostridioides difficile; Clostridium Infections; Europe; Humans; Metronidazole; North America; Recurrence; Treatment Failure; Vancomycin

2012
Current strategies for management of initial Clostridium difficile infection.
    Journal of hospital medicine, 2012, Volume: 7 Suppl 3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin

2012
Novel management strategies in the treatment of severe Clostridium difficile infection.
    Advances in surgery, 2012, Volume: 46

    Topics: Algorithms; Anti-Infective Agents; Colectomy; Enterocolitis, Pseudomembranous; Humans; Ileostomy; Immunization; Metronidazole; Prognosis; Recurrence; Risk Factors; Vancomycin

2012
[Treatment of refractory or recurrent Clostridium difficile infection].
    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:2

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Probiotics; Recurrence; Vancomycin

2012
Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18 Suppl 6

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Recurrence; Vancomycin

2012
[Treatment of infections associated with Clostridium difficile].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2003, Volume: 56, Issue:5-6

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Species Specificity; Vancomycin

2003
Recurrent Enterococcus faecalis endophthalmitis after phacoemulsification.
    Journal of cataract and refractive surgery, 2005, Volume: 31, Issue:3

    Topics: Amikacin; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Vancomycin; Vitrectomy

2005
Past, present, and future therapies for Clostridium difficile-associated disease.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12

    Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Forecasting; Humans; Metronidazole; Probiotics; Recurrence; Vancomycin

2006
Clostridium difficile-associated disease.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2006, Volume: 59, Issue:12

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Recurrence; Risk Factors; Saccharomyces; Vancomycin

2006
Clostridium difficile: dealing with a silent menace.
    British journal of community nursing, 2007, Volume: 12, Issue:7

    Topics: Anti-Bacterial Agents; Antidiarrheals; Clostridioides difficile; Clostridium Infections; Disinfection; Drug Prescriptions; Early Diagnosis; Humans; Incidence; Infection Control; Population Surveillance; Primary Prevention; Recurrence; Risk Factors; United Kingdom; Vancomycin

2007
Treatment of Clostridium difficile infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Jan-15, Volume: 46 Suppl 1

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Disease Management; Enterocolitis, Pseudomembranous; Humans; Metronidazole; North America; Recurrence; Therapies, Investigational; Vancomycin

2008
Antibiotic-associated colitis.
    Disease-a-month : DM, 1984, Volume: 30, Issue:15

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cholestyramine Resin; Clindamycin; Clostridium; Clostridium Infections; Colitis; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Fluid Therapy; Humans; Metronidazole; Recurrence; Staphylococcal Infections; Vancomycin

1984
Treatment of pseudomembranous colitis and antibiotic-associated diarrhoea.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14 Suppl D

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Recurrence; Vancomycin

1984
Update on Clostridium difficile-induced colitis, Part 2.
    American journal of hospital pharmacy, 1994, Aug-01, Volume: 51, Issue:15

    Topics: Administration, Oral; Anti-Bacterial Agents; Capsules; Clostridioides difficile; Drug Costs; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

1994
Multifocal metachronous epidural abscesses of the spine. A case report.
    Spine, 1996, May-01, Volume: 21, Issue:9

    Topics: Abscess; Aged; Cervical Vertebrae; Drainage; Epidural Space; Female; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Recurrence; Retrospective Studies; Spinal Diseases; Staphylococcal Infections; Vancomycin

1996
Infectious complications of peritoneal dialysis.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1997, Volume: 17 Suppl 3

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Catheterization; Dialysis Solutions; Drug Resistance, Microbial; Equipment Design; Forecasting; Humans; Macrophages, Peritoneal; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Vancomycin

1997
Clostridium difficile infection.
    Annual review of medicine, 1998, Volume: 49

    Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Colon; Diarrhea; Drug Costs; Drug Resistance, Microbial; Enterocolitis, Pseudomembranous; Exotoxins; Feces; Hospitalization; Humans; Intestinal Mucosa; Metronidazole; Recurrence; Time Factors; Vancomycin

1998
Update on Clostridium difficile infection.
    Current gastroenterology reports, 2000, Volume: 2, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2000
Recurrent Clostridium difficile diarrhoea.
    Gut, 2001, Volume: 49, Issue:1

    Topics: Anion Exchange Resins; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin

2001
Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature.
    Journal of Korean medical science, 2002, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bioprosthesis; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Humans; Male; Mitral Valve; Recurrence; Stenotrophomonas maltophilia; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2002
Clostridium difficile infection: responses, relapses and re-infections.
    The Journal of hospital infection, 1992, Volume: 22, Issue:2

    Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin

1992
[Current status of Clostridium difficile: recent advances in diagnostic materials and treatment of colitis and diarrheas associated with antibiotic therapy].
    Annales de gastroenterologie et d'hepatologie, 1991, Volume: 27, Issue:7

    Topics: Causality; Clinical Protocols; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Recurrence; Vancomycin

1991

Trials

39 trial(s) available for vancomycin and Recrudescence

ArticleYear
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
    Contemporary clinical trials, 2022, Volume: 116

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; COVID-19; Diarrhea; Fidaxomicin; Humans; Recurrence; Treatment Outcome; Vancomycin

2022
Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
    Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:9

    Topics: Clostridioides; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Humans; Recurrence; Treatment Outcome; Vancomycin

2021
The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Japan; Male; Metronidazole; Placebos; Recurrence; Time Factors; Vancomycin

2018
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 01-18, Volume: 66, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cost-Benefit Analysis; Female; Humans; Male; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Recurrence; Secondary Prevention; Vancomycin

2018
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 08-16, Volume: 67, Issue:5

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Risk Factors; Secondary Prevention; Vancomycin; Young Adult

2018
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.
    The Journal of antimicrobial chemotherapy, 2018, 09-01, Volume: 73, Issue:9

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; England; Female; Fidaxomicin; Humans; Male; Middle Aged; Quality of Life; Recurrence; Treatment Outcome; Vancomycin

2018
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Trials, 2018, Jun-01, Volume: 19, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cause of Death; Daptomycin; Drug Resistance, Bacterial; Early Termination of Clinical Trials; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Recurrence; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin

2018
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Hospitalization; Humans; Japan; Male; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome; Vancomycin; Young Adult

2018
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
    Gastroenterology, 2019, Volume: 156, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Denmark; Fecal Microbiota Transplantation; Female; Fidaxomicin; Humans; Male; Middle Aged; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vancomycin; Young Adult

2019
Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Fidaxomicin; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Ribotyping; Treatment Outcome; Vancomycin

2019
[Challenges of Clostridium difficile infection].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013, Volume: 108, Issue:8

    Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin

2013
Risk estimation for recurrent Clostridium difficile infection based on clinical factors.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10

    Topics: Adult; Age Factors; Aged; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Creatine; Female; Fidaxomicin; Humans; Male; Middle Aged; Models, Statistical; Multivariate Analysis; Recurrence; Risk Factors; Vancomycin; Young Adult

2014
Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Polymers; Recurrence; Sulfonic Acids; Vancomycin; Young Adult

2014
Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazolidinones; Patient Safety; Recurrence; Vancomycin

2015
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin

2016
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Recurrence; Treatment Outcome; Vancomycin

2016
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Feb-01, Volume: 64, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Female; Humans; Male; Microbiota; Middle Aged; Ontario; Recurrence; Vancomycin; Young Adult

2017
Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Fidaxomicin; Humans; Male; Middle Aged; Molecular Typing; Polymorphism, Restriction Fragment Length; Prohibitins; Recurrence; Treatment Outcome; Vancomycin

2012
Duodenal infusion of donor feces for recurrent Clostridium difficile.
    The New England journal of medicine, 2013, Jan-31, Volume: 368, Issue:5

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Diarrhea; Duodenum; Feces; Female; Humans; Intubation, Gastrointestinal; Male; Metagenome; Middle Aged; Recurrence; Therapeutic Irrigation; Vancomycin

2013
Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Feces; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Postoperative Complications; Pouchitis; Proctocolectomy, Restorative; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Vancomycin

2013
Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    The American journal of gastroenterology, 2002, Volume: 97, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Remission Induction; Risk Factors; Vancomycin

2002
Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Skin Diseases, Infectious; Streptococcus agalactiae; Treatment Outcome; Vancomycin

2007
Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures.
    American journal of diseases of children (1960), 1984, Volume: 138, Issue:1

    Topics: Adolescent; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Eruptions; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Premedication; Prospective Studies; Random Allocation; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin

1984
Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrol
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1995, Volume: 11

    Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Teicoplanin; Vancomycin

1995
[Antibiotic prophylaxis with ++vancomycin in corrective surgery with alloplastic material].
    Minerva chirurgica, 1995, Volume: 50, Issue:9

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biocompatible Materials; Hernia, Inguinal; Hernia, Ventral; Humans; Recurrence; Vancomycin

1995
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:5

    Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fusidic Acid; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Teicoplanin; Vancomycin

1996
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Risk Factors; Seasons; Vancomycin

1997
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
    Infection control and hospital epidemiology, 1999, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Health Care Costs; Hospitalization; Humans; Incidence; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

1999
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cells, Cultured; Clostridium Infections; Feces; Humans; Metronidazole; Placebos; Recurrence; Saccharomyces; Time Factors; Vancomycin

1999
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Combined Modality Therapy; Double-Blind Method; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Probiotics; Recurrence; Saccharomyces; Vancomycin

2000
Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1992, Volume: 8

    Topics: Female; Humans; Imipenem; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Vancomycin

1992
Is initial (24 hours) lavage necessary in treatment of CAPD peritonitis?
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1991, Volume: 11, Issue:1

    Topics: Acute Disease; Bacterial Infections; Humans; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritoneal Lavage; Peritonitis; Recurrence; Vancomycin

1991
Initial treatment of dialysis associated peritonitis: a controlled trial of vancomycin versus cefazolin.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1991, Volume: 11, Issue:1

    Topics: Adult; Cefazolin; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin

1991
Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1989, Volume: 9, Issue:1

    Topics: Catheters, Indwelling; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Urokinase-Type Plasminogen Activator; Vancomycin

1989
Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1989, Volume: 5

    Topics: Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Vancomycin

1989
Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
    The American journal of gastroenterology, 1989, Volume: 84, Issue:10

    Topics: Antidiarrheals; Clinical Trials as Topic; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin; Yeast, Dried

1989
Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 21 Suppl A

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Glycopeptides; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Random Allocation; Recurrence; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

1988
Antibiotic-associated colitis caused by Clostridium difficile: relapse and risk factors.
    The Medical journal of Australia, 1986, Mar-17, Volume: 144, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Colitis; Feces; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Recurrence; Risk; Vancomycin

1986
Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial.
    Archives of internal medicine, 1986, Volume: 146, Issue:6

    Topics: Aged; Bacitracin; Clinical Trials as Topic; Clostridium; Clostridium Infections; Diarrhea; Double-Blind Method; Feces; Female; Humans; Male; Middle Aged; Random Allocation; Recurrence; Time Factors; Vancomycin

1986

Other Studies

258 other study(ies) available for vancomycin and Recrudescence

ArticleYear
Salicylanilide Analog Minimizes Relapse of
    Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Male; Mice; Mice, Inbred C57BL; Recurrence; Safety; Salicylanilides; Tissue Distribution

2020
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27 Suppl 2

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Fidaxomicin; Humans; Practice Guidelines as Topic; Recurrence; Societies, Medical; Vancomycin

2021
Non-inferiority of metronidazole to vancomycin in the treatment of first episode non-severe Clostridioides difficile infection: a single center retrospective cohort study.
    Infection, 2022, Volume: 50, Issue:4

    Topics: Adult; Aftercare; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Hospital Mortality; Humans; Infant, Newborn; Metronidazole; Patient Discharge; Recurrence; Retrospective Studies; Vancomycin

2022
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cohort Studies; Fidaxomicin; Humans; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2022
Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
    European journal of cancer (Oxford, England : 1990), 2022, Volume: 171

    Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Neoplasms; Recurrence; Retrospective Studies; Vancomycin

2022
Efficacy of Omadacycline or Vancomycin Combined With Germinants for Preventing Clostridioides difficile Relapse in a Murine Model.
    The Journal of infectious diseases, 2023, 03-01, Volume: 227, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Clostridioides; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Mice; Recurrence; Vancomycin; Weight Loss

2023
The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.
    Applied microbiology and biotechnology, 2022, Volume: 106, Issue:19-20

    Topics: Animals; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Granulocyte Colony-Stimulating Factor; Inflammation Mediators; Interleukin-6; Mice; Raffinose; Recurrence; Treatment Outcome; Tryptophan; Tumor Necrosis Factor-alpha; Valine; Vancomycin

2022
Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent
    The New England journal of medicine, 2023, 02-16, Volume: 388, Issue:7

    Topics: Administration, Oral; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Secondary Prevention; Vancomycin

2023
Live fecal microbiota oral capsules (Vowst) for prevention of CDI recurrence.
    The Medical letter on drugs and therapeutics, 2023, 05-29, Volume: 65, Issue:1677

    Topics: Anti-Bacterial Agents; Capsules; Clostridium Infections; Humans; Microbiota; Recurrence; Vancomycin

2023
Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease.
    Journal of gastroenterology and hepatology, 2023, Volume: 38, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Humans; Inflammatory Bowel Diseases; Male; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2023
    International journal of molecular sciences, 2023, Sep-27, Volume: 24, Issue:19

    Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fecal Microbiota Transplantation; Feces; Humans; Mice; Recurrence; Treatment Outcome; Vancomycin

2023
Risk factors for Recurrent Clostridioides Difficile Infection in Children.
    Hospital pediatrics, 2023, 11-01, Volume: 13, Issue:11

    Topics: Anti-Bacterial Agents; Child; Chronic Disease; Clostridioides difficile; Clostridium Infections; Female; Humans; Metronidazole; Recurrence; Risk Factors; Vancomycin

2023
Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore.
    Scientific reports, 2019, 09-17, Volume: 9, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Diarrhea; Female; Humans; Intensive Care Units; Male; Metronidazole; Recurrence; Risk Factors; Singapore; Treatment Outcome; Vancomycin

2019
Clinical Predictors of Recurrence After Primary Clostridioides difficile Infection: A Prospective Cohort Study.
    Digestive diseases and sciences, 2020, Volume: 65, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Risk Factors; Vancomycin

2020
Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 90

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Female; Fidaxomicin; Hospitalization; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Risk Factors; Vancomycin

2020
Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    The American journal of gastroenterology, 2019, Volume: 114, Issue:12

    Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Duration of Therapy; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Recurrence; Vancomycin; Young Adult

2019
Effect of Induced Membrane Formation Followed by Polymethylmethacrylate Implantation on Diabetic Foot Ulcer Healing When Revascularization Is Not Feasible.
    Journal of diabetes research, 2019, Volume: 2019

    Topics: Abscess; Aged; Amputation, Surgical; Anti-Bacterial Agents; Bone Cements; Case-Control Studies; Debridement; Diabetic Foot; Female; Gangrene; Gentamicins; Humans; Male; Membranes; Middle Aged; Osteomyelitis; Peripheral Arterial Disease; Polymethyl Methacrylate; Recurrence; Retrospective Studies; Survival Rate; Time Factors; Vancomycin; Wound Healing; Wound Infection

2019
Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
    Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:9

    Topics: Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridium Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Fecal Microbiota Transplantation; Fidaxomicin; Health Personnel; Hong Kong; Humans; Inflammatory Bowel Diseases; Public Health; Quality-Adjusted Life Years; Recurrence; Treatment Outcome; Vancomycin

2020
Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: Not Ready for Prime Time.
    JAMA, 2020, 02-11, Volume: 323, Issue:6

    Topics: Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Vancomycin

2020
Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Drug Administration Routes; Female; Hospitalization; Hospitals; Humans; Immunoenzyme Techniques; Incidence; Inpatients; Japan; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Vancomycin

2020
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Drug Utilization Review; Female; Fidaxomicin; Humans; Japan; Length of Stay; Male; Metronidazole; Middle Aged; Network Meta-Analysis; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Recurrence; Vancomycin

2020
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
    Scientific reports, 2020, 05-07, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Arthritis, Rheumatoid; Auranofin; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Repositioning; Fidaxomicin; Gastrointestinal Tract; Humans; Mice; Microbial Sensitivity Tests; Recurrence; Vancomycin

2020
In MRSA bacteremia, adding a β-lactam to usual care did not improve a composite outcome at 90 days.
    Annals of internal medicine, 2020, 06-16, Volume: 172, Issue:12

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Recurrence; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin

2020
Mandated IOL Removal for Cure of Recurrent Enterococcus Faecalis Endophthalmitis: A Case Report.
    Ocular immunology and inflammation, 2021, Nov-17, Volume: 29, Issue:7-8

    Topics: Aged; Anti-Bacterial Agents; Device Removal; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microscopy, Acoustic; Phacoemulsification; Recurrence; Slit Lamp Microscopy; Vancomycin; Visual Acuity; Vitreous Body

2021
Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
    Clinical and translational gastroenterology, 2020, Volume: 11, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Clostridioides; Clostridium Infections; Comorbidity; Diagnostic Errors; Female; Fidaxomicin; Humans; Incidence; Lactulose; Laxatives; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Failure; Vancomycin

2020
Optimal vancomycin dose in the treatment of
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3

    Topics: Age Factors; Aged; Aged, 80 and over; Antimicrobial Stewardship; Clostridioides difficile; Clostridium Infections; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Patient Readmission; Recurrence; Retrospective Studies; Serum Albumin; Severity of Illness Index; Sex Factors; Vancomycin

2021
Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Digestive diseases and sciences, 2020, Volume: 65, Issue:11

    Topics: Anti-Bacterial Agents; Cholangitis, Sclerosing; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Colonoscopy; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Vancomycin; Young Adult

2020
Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.
    The Journal of infection, 2020, Volume: 81, Issue:5

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Fecal Microbiota Transplantation; Humans; Microbiota; Recurrence; Treatment Outcome; Vancomycin

2020
Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 103

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Fidaxomicin; Hospitalization; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Recurrence; Treatment Outcome; Vancomycin

2021
Recurrent Clostridium difficile infection treated with bezlotoxumab in a liver transplant patient.
    Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:10

    Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Broadly Neutralizing Antibodies; Clostridioides difficile; Clostridium Infections; Humans; Male; Middle Aged; Recurrence; Vancomycin

2021
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Utilization; Female; Fidaxomicin; Humans; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin

2021
Effectiveness of fidaxomicin versus oral vancomycin in the treatment of recurrent clostridioides difficile.
    Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Comorbidity; Drug Administration Routes; Female; Fidaxomicin; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin

2021
Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
    International journal of antimicrobial agents, 2021, Volume: 57, Issue:4

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Standard of Care; Treatment Outcome; Vancomycin

2021
Single-Stage Revision for Chronic Fungal Periprosthetic Joint Infection: An Average of 5 Years of Follow-Up.
    The Journal of arthroplasty, 2017, Volume: 32, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Infectious; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Debridement; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Knee Prosthesis; Male; Middle Aged; Mycoses; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin

2017
An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:10

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Disease Outbreaks; Female; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Recurrence; Ribotyping; Risk Factors; Spain; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult

2017
Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflammatory bowel diseases, 2017, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Clostridium Infections; Colectomy; Cross-Sectional Studies; Escherichia coli; Feces; Female; Humans; Incidence; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; New York City; Polymerase Chain Reaction; Recurrence; Vancomycin; Young Adult

2017
Epidemiology of Methicillin-Resistant
    Pediatrics, 2017, Volume: 139, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Child; Community-Acquired Infections; Female; Hospitalization; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Musculoskeletal Diseases; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Treatment Failure; Vancomycin; Vascular Diseases

2017
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 10-01, Volume: 65, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Female; Humans; Male; Microbiota; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Vancomycin; Young Adult

2017
Vancomycin Taper and Pulse Regimen With Careful Follow-up for Patients With Recurrent Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Oct-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Vancomycin

2017
Vancomycin vs Metronidazole for Clostridium difficile infection: focus on recurrence and mortality.
    Internal and emergency medicine, 2017, Volume: 12, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Recurrence; Risk Assessment; Secondary Prevention; Survival Analysis; Treatment Outcome; United States; Vancomycin

2017
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
    World journal of surgery, 2018, Volume: 42, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin

2018
An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.
    PloS one, 2017, Volume: 12, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Computer Simulation; Drug Administration Schedule; Drug Dosage Calculations; Humans; Microbial Sensitivity Tests; Models, Statistical; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin

2017
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
    Medecine et maladies infectieuses, 2017, Volume: 47, Issue:8

    Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin

2017
Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients.
    The Annals of pharmacotherapy, 2018, Volume: 52, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Female; Humans; Kidney Transplantation; Male; Middle Aged; Recurrence; Secondary Prevention; Transplant Recipients; Vancomycin

2018
Recurrent bacteremia and liver abscess caused by Clostridium difficile: A case report.
    Medicine, 2017, Volume: 96, Issue:35

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clostridioides difficile; Clostridium Infections; Humans; Liver Abscess; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metronidazole; Recurrence; Vancomycin

2017
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
    BMJ case reports, 2017, Sep-25, Volume: 2017

    Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Combination; Humans; Liver Function Tests; Liver Transplantation; Male; Postoperative Complications; Prednisolone; Recurrence; Treatment Outcome; Vancomycin

2017
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Inpatients; Leukocyte Count; Male; Metronidazole; Middle Aged; Neutrophils; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2019
Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
    Infection control and hospital epidemiology, 2018, Volume: 39, Issue:3

    Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Regression, Psychology; Retrospective Studies; Risk Factors; Treatment Outcome; United States; Vancomycin; Young Adult

2018
Use of modular megaprosthesis in managing chronic end-stage periprosthetic hip and knee infections: Is there an increase in relapse rate?
    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2018, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Bone Resorption; Bone Transplantation; Female; Femur; Follow-Up Studies; Gentamicins; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Osteomyelitis; Pain, Postoperative; Patient Satisfaction; Prostheses and Implants; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Salvage Therapy; Vancomycin; Young Adult

2018
BILATERAL ENTEROCOCCUS FAECALIS ENDOPHTHALMITIS WITH MULTIPLE RECURRENCES.
    Retinal cases & brief reports, 2021, Jan-01, Volume: 15, Issue:1

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Male; Microscopy, Electron; Recurrence; Secondary Prevention; Ultrasonography; Vancomycin; Visual Acuity; Vitrectomy

2021
Repeated Clostridium difficile infection after living donor liver transplantation.
    Clinical journal of gastroenterology, 2018, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Immunosuppressive Agents; Length of Stay; Liver Transplantation; Living Donors; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Vancomycin

2018
Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Metronidazole; Middle Aged; Organ Transplantation; Recurrence; Retrospective Studies; Transplant Recipients; Treatment Outcome; Vancomycin

2018
Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by
    BMJ case reports, 2018, Mar-20, Volume: 2018

    Topics: Age of Onset; Aged; Anti-Bacterial Agents; Common Variable Immunodeficiency; Drug Resistance, Bacterial; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lung; Male; Pneumonia, Staphylococcal; Recurrence; Staphylococcus lugdunensis; Vancomycin

2018
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2018, Apr-25, Volume: 108, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin

2018
Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
    International journal of colorectal disease, 2018, Volume: 33, Issue:9

    Topics: Adult; Age Factors; Ambulatory Care; Anti-Bacterial Agents; Anti-Inflammatory Agents; Brazil; Clostridium Infections; Colitis, Ulcerative; Crohn Disease; Disease Progression; Female; Humans; Infliximab; Male; Middle Aged; Prevalence; Prospective Studies; Recurrence; Risk Factors; Sex Factors; Steroids; Time Factors; Treatment Outcome; Vancomycin

2018
Diagnosis and Treatment of Clostridium difficile Infection.
    JAMA, 2018, Sep-11, Volume: 320, Issue:10

    Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Fidaxomicin; Humans; Nucleic Acid Amplification Techniques; Practice Guidelines as Topic; Recurrence; Vancomycin

2018
Treatment of Suspected Invasive Fungal Infection in War Wounds.
    Military medicine, 2018, 09-01, Volume: 183, Issue:suppl_2

    Topics: Administration, Topical; Afghan Campaign 2001-; Amphotericin B; Antifungal Agents; beta-Cyclodextrins; Debridement; Excipients; Humans; Mycoses; Recurrence; Risk Factors; Tobramycin; Treatment Outcome; Triazoles; Vancomycin; Voriconazole; Wounds and Injuries

2018
A Case of Recurring Diarrhea in a Young Woman.
    Gastroenterology, 2019, Volume: 156, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Klebsiella Infections; Klebsiella oxytoca; Recurrence; Vancomycin

2019
Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Journal of pediatric gastroenterology and nutrition, 2019, Volume: 68, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Child; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Inflammatory Bowel Diseases; Longitudinal Studies; Male; Recurrence; Retrospective Studies; Severity of Illness Index; Vancomycin

2019
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection.
    Journal of clinical pharmacy and therapeutics, 2019, Volume: 44, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridium Infections; Female; Fidaxomicin; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin

2019
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Databases, Factual; Disease Management; Female; Fidaxomicin; Humans; Male; Middle Aged; Propensity Score; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United States; Vancomycin

2019
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection.
    BMC infectious diseases, 2019, Jan-14, Volume: 19, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2019
Recurrent Clostridioides (Clostridium) difficile infection in a patient suffering from inflammatory bowel disease and benefits of resistotyping.
    Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Typing Techniques; Clostridioides difficile; Clostridium Infections; Colitis, Ulcerative; Feces; Humans; Male; Multilocus Sequence Typing; Recurrence; Vancomycin

2019
Recurrent
    Korean journal of ophthalmology : KJO, 2019, Volume: 33, Issue:2

    Topics: Aged; Dexamethasone; DNA, Bacterial; Drug Therapy, Combination; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Glucocorticoids; Gram-Positive Bacterial Infections; Humans; Intravitreal Injections; Recurrence; Vancomycin; Vitreous Body

2019
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Inpatients; Japan; Logistic Models; Male; Metronidazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2019
Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses.
    Infection control and hospital epidemiology, 2019, Volume: 40, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Logistic Models; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Vancomycin

2019
Clostridium difficile: A Frequent Infection in Children After Intestinal Transplantation.
    Transplantation, 2020, Volume: 104, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Cross-Sectional Studies; Diarrhea; Feces; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Intestine, Small; Male; Metronidazole; Postoperative Complications; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2020
Does oral vancomycin prophylaxis during systemic antibiotic exposure prevent Clostridioides difficile infection relapses? Still in search of an answer.
    Infection control and hospital epidemiology, 2019, Volume: 40, Issue:9

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Recurrence; Vancomycin

2019
High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    PloS one, 2019, Volume: 14, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Humans; Linezolid; Microbiota; Quorum Sensing; Recurrence; Ribotyping; Spores, Bacterial; Vancomycin; Virulence Factors

2019
A unique case of peroneus brevis/longus myositis in a patient with a STAT3 mutation.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013, Volume: 110, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Disease-Free Survival; Humans; Job Syndrome; Male; Muscles; Mutation; Myositis; Recurrence; STAT3 Transcription Factor; Vancomycin

2013
Reconstruction of achilles rerupture with peroneus longus tendon transfer.
    Foot & ankle international, 2013, Volume: 34, Issue:6

    Topics: Achilles Tendon; Adult; Anti-Bacterial Agents; Female; Humans; Magnetic Resonance Imaging; Recurrence; Rupture; Staphylococcal Infections; Staphylococcus epidermidis; Tendon Transfer; Vancomycin

2013
Salmonella enterica serovar Minnesota urosepsis in a patient with Crohn's disease in the absence of recent or current gastrointestinal symptoms.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9

    Topics: Adult; Antibodies, Monoclonal; Ceftriaxone; Crohn Disease; Humans; Infliximab; Male; Meropenem; Recurrence; Salmonella enterica; Salmonella Infections; Sepsis; Thienamycins; Urinary Catheters; Urinary Tract Infections; Urolithiasis; Vancomycin

2013
Effect of vancomycin dose on treatment outcomes in severe Clostridium difficile infection.
    International journal of antimicrobial agents, 2013, Volume: 42, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Diarrhea; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Vancomycin

2013
[Clostridium difficile infection (CDI) in the course of time - an issue only for the internist?].
    Zentralblatt fur Chirurgie, 2014, Volume: 139, Issue:4

    Topics: Aminoglycosides; Clostridioides difficile; Colectomy; Colostomy; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Germany; Humans; Incidence; Metronidazole; Recurrence; Transplantation; Vancomycin

2014
Industrially prefabricated cement spacers: do vancomycin- and gentamicin-impregnated spacers offer any advantage?
    Clinical orthopaedics and related research, 2014, Volume: 472, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bone Cements; Chi-Square Distribution; Coated Materials, Biocompatible; Device Removal; Female; Gentamicins; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Patient Satisfaction; Prosthesis-Related Infections; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vancomycin

2014
Photo recall reaction following the use of vancomycin.
    Dermatology online journal, 2013, Nov-15, Volume: 19, Issue:11

    Topics: Anti-Bacterial Agents; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Recurrence; Sunburn; Vancomycin

2013
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Journal of gastrointestinal and liver diseases : JGLD, 2013, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult

2013
Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Tolerance; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult

2014
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:2

    Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin

2014
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, University; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Texas; Vancomycin

2014
Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 30

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Vancomycin; Vancomycin Resistance

2015
Residual renal function in patients on peritoneal dialysis: effect of peritonitis episodes.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2014, Nov-17, Volume: 34, Issue:6

    Topics: Adult; Aged; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Renal Dialysis; Retrospective Studies; Tobramycin; Vancomycin

2014
Emphysematous cystitis due to recurrent Clostridium difficile infection.
    BMJ case reports, 2014, Dec-17, Volume: 2014

    Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cystitis; Emphysema; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Metronidazole; Recurrence; Urinary Bladder; Vancomycin

2014
SMT19969 for Clostridium difficile infection (CDI): in vivo efficacy compared with fidaxomicin and vancomycin in the hamster model of CDI.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:6

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzimidazoles; Clostridioides difficile; Clostridium Infections; Disease Models, Animal; Fidaxomicin; Gastrointestinal Tract; Mesocricetus; Microbial Sensitivity Tests; Plasma; Pyridines; Recurrence; Survival Analysis; Treatment Outcome; Vancomycin

2015
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae.
    The American journal of medicine, 2015, Volume: 128, Issue:7

    Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin

2015
Impact of Clostridium difficile recurrence on hospital readmissions.
    American journal of infection control, 2015, Apr-01, Volume: 43, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Fluoroquinolones; Humans; Intensive Care Units; Linezolid; Multivariate Analysis; Patient Readmission; Recurrence; Regression Analysis; Retrospective Studies; Vancomycin

2015
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clostridioides difficile; Colitis; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; Random Allocation; Recurrence; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Weight Loss

2015
Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders.
    The American journal of gastroenterology, 2015, Volume: 110, Issue:4

    Topics: Abdominal Pain; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biological Therapy; Capsules; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Feces; Female; Fidaxomicin; Freezing; Humans; Irritable Bowel Syndrome; Male; Metronidazole; Microbiota; Recurrence; Transplantation, Homologous; Treatment Outcome; Vancomycin

2015
Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:8

    Topics: Administrative Claims, Healthcare; Aged; Algorithms; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; Clostridioides difficile; Drug Prescriptions; Enterocolitis, Pseudomembranous; Feces; Female; Humans; International Classification of Diseases; Male; Middle Aged; Population Surveillance; Predictive Value of Tests; Recurrence; ROC Curve; Vancomycin

2015
Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Gastrointestinal Tract; Humans; Middle Aged; Models, Theoretical; Recurrence; Treatment Outcome; Vancomycin

2015
Adynamic ileus and diarrhoea: a rare adverse effect of antidepressants.
    BMJ case reports, 2015, May-29, Volume: 2015

    Topics: Aged; Anti-Bacterial Agents; Antidepressive Agents; Colonoscopy; Diarrhea; Female; Humans; Iatrogenic Disease; Ileus; Metronidazole; Parenteral Nutrition; Recurrence; Treatment Outcome; Vancomycin

2015
Broncholithiasis presenting as bronchiectasis and recurrent pneumonias.
    BMJ case reports, 2015, Jun-23, Volume: 2015

    Topics: Anti-Bacterial Agents; Bronchial Diseases; Bronchiectasis; Bronchoalveolar Lavage; Chest Pain; Dyspnea; Female; Fever; Humans; Lithiasis; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Recurrence; Treatment Outcome; Vancomycin

2015
[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
    Revista medica de Chile, 2015, Volume: 143, Issue:4

    Topics: Clostridioides difficile; Clostridium Infections; Diarrhea; Fecal Microbiota Transplantation; Female; Humans; Middle Aged; Recurrence; Vancomycin

2015
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
    JAMA internal medicine, 2015, Volume: 175, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment

2015
Evaluation of a bedside scoring system for predicting clinical cure and recurrence of Clostridium difficile infections.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Nov-01, Volume: 72, Issue:21

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Female; Humans; Male; Metronidazole; Middle Aged; Point-of-Care Testing; Predictive Value of Tests; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2015
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Mar-01, Volume: 62, Issue:5

    Topics: Anti-Bacterial Agents; Canada; Clostridioides difficile; Cohort Studies; Cost of Illness; Enterocolitis, Pseudomembranous; Hospitalization; Incidence; Metronidazole; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2016
Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Clinical therapeutics, 2016, Jan-01, Volume: 38, Issue:1

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Propensity Score; Recurrence; Regression Analysis; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin

2016
Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Load; Bacteroides fragilis; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Tract; Humans; Microbiota; Models, Biological; Recurrence; Vancomycin

2016
Chronic Recurrent Pseudophakic Endophthalmitis.
    JAMA ophthalmology, 2016, Volume: 134, Issue:4

    Topics: Aged, 80 and over; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Female; Follow-Up Studies; Humans; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Recurrence; Risk Assessment; Slit Lamp; Treatment Outcome; Vancomycin; Vitrectomy

2016
Small-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Multilocus Sequence Typing; Phenotype; Recurrence; Staphylococcal Infections; Surgical Wound Infection; Vancomycin

2016
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
    Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:12

    Topics: Anti-Bacterial Agents; Australia; Clostridioides difficile; Cost Savings; Cost-Benefit Analysis; Drug Costs; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Health Care Costs; Humans; Intestines; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Time Factors; Treatment Outcome; Vancomycin

2016
Clostridium difficile Associated Diarrhea.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2016, Volume: 69, Issue:3

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Vancomycin

2016
[Antibiotic treatment of clostridial colitis].
    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2016,Winter, Volume: 65, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Recurrence; Vancomycin

2016
First description of late recurrence of catheter-associated bacteraemia due to Cellulosimicrobium cellulans.
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:2

    Topics: Actinobacteria; Adenocarcinoma; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Female; Humans; Immunocompromised Host; Middle Aged; Rectal Neoplasms; Recurrence; Vancomycin; Vascular Access Devices

2017
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
    BMC infectious diseases, 2016, 06-22, Volume: 16

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Hospitalization; Hospitals; Humans; Immunoassay; Inflammation; Israel; Leukocyte L1 Antigen Complex; Leukocytosis; Male; Metronidazole; Middle Aged; Recurrence; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult

2016
Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:12

    Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Enterocolitis, Pseudomembranous; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Minocycline; Recurrence; Retrospective Studies; Sepsis; Tigecycline; Treatment Outcome; Vancomycin

2016
Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections.
    The American journal of gastroenterology, 2016, Volume: 111, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cohort Studies; Female; Humans; Male; Middle Aged; Proportional Hazards Models; Quebec; Recurrence; Retrospective Studies; Secondary Prevention; Vancomycin; Young Adult

2016
Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Diarrhea; Female; Humans; Infant; Infant, Newborn; Italy; Male; Metronidazole; Prevalence; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome; Vancomycin

2017
Impact of Initial Vancomycin Trough Concentration on Clinical and Microbiological Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Journal of Korean medical science, 2017, Volume: 32, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Bacteremia; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Recurrence; Retrospective Studies; Risk Factors; ROC Curve; Survival Rate; Vancomycin

2017
An institutional comparison of total abdominal colectomy and diverting loop ileostomy and colonic lavage in the treatment of severe, complicated Clostridium difficile infections.
    American journal of surgery, 2017, Volume: 213, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Clostridium Infections; Colectomy; Colon; Female; Humans; Ileostomy; Male; Metronidazole; Middle Aged; Organ Sparing Treatments; Recurrence; Retrospective Studies; Severity of Illness Index; Therapeutic Irrigation; Vancomycin; Virginia

2017
Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.
    PloS one, 2017, Volume: 12, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Community-Acquired Infections; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Enterocolitis, Pseudomembranous; Fecal Microbiota Transplantation; Fidaxomicin; France; Health Care Costs; Humans; Models, Economic; Quality-Adjusted Life Years; Recurrence; Vancomycin

2017
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
    Journal of medical economics, 2017, Volume: 20, Issue:7

    Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; France; Hospitalization; Humans; Markov Chains; Models, Economic; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; Severity of Illness Index; Vancomycin

2017
Beyond MRSA: the growing menace of hVISA and VISA.
    Southern medical journal, 2008, Volume: 101, Issue:6

    Topics: Anti-Bacterial Agents; Daptomycin; Debridement; Discitis; Drug Resistance, Multiple, Bacterial; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Recurrence; Retreatment; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Thoracic Vertebrae; Vancomycin; Vancomycin Resistance

2008
Direct demonstration of viable Staphylococcus aureus biofilms in an infected total joint arthroplasty. A case report.
    The Journal of bone and joint surgery. American volume, 2008, Volume: 90, Issue:8

    Topics: Arthroplasty, Replacement; Biofilms; Combined Modality Therapy; Debridement; Device Removal; Diagnosis, Differential; Elbow Joint; Fractures, Ununited; Humans; Humeral Fractures; Internal Fixators; Male; Microscopy, Confocal; Middle Aged; Prosthesis Failure; Prosthesis-Related Infections; Radiography; Recurrence; Rifampin; Staphylococcal Infections; Vancomycin

2008
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
    Nederlands tijdschrift voor geneeskunde, 2008, Aug-30, Volume: 152, Issue:35

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Male; Middle Aged; Recurrence; Treatment Outcome; Vancomycin

2008
Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis.
    Pediatric nephrology (Berlin, Germany), 2009, Volume: 24, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Corynebacterium; Corynebacterium Infections; Drug Combinations; Humans; Male; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Treatment Outcome; Vancomycin

2009
Sternectomy and sternum reconstruction for infection after cardiac surgery.
    The Annals of thoracic surgery, 2008, Volume: 86, Issue:5

    Topics: Cardiac Surgical Procedures; Drainage; Humans; Male; Middle Aged; Pericardial Effusion; Recurrence; Sternum; Surgical Wound Infection; Vancomycin

2008
[Pneumococcal meningitis in children--9 1/2-year-experience at Szent László Hospital, Budapest, Hungary].
    Ideggyogyaszati szemle, 2008, Nov-30, Volume: 61, Issue:11-12

    Topics: Adolescent; Anti-Bacterial Agents; Ataxia; Ceftriaxone; Child; Child, Preschool; Female; Follow-Up Studies; Hospital Departments; Humans; Hungary; Infant; Infant, Newborn; Intellectual Disability; Intensive Care Units, Pediatric; Length of Stay; Male; Medical Records; Meningitis, Pneumococcal; Muscle Hypotonia; Pneumococcal Vaccines; Recurrence; Respiration, Artificial; Retrospective Studies; Urinary Bladder, Neurogenic; Vaccines, Conjugate; Vancomycin

2008
Varicella reactivation presenting as shingles and aseptic meningitis in an immunocompetent 11-year-old boy.
    Clinical pediatrics, 2009, Volume: 48, Issue:4

    Topics: Acyclovir; Anti-Bacterial Agents; Antibodies, Viral; Antiviral Agents; Cefotaxime; Chickenpox; Child; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Meningitis, Aseptic; Polymerase Chain Reaction; Recurrence; Spinal Puncture; Vancomycin

2009
[The approach to recurrent infections with Clostridium difficile].
    Harefuah, 2008, Volume: 147, Issue:11

    Topics: Anti-Bacterial Agents; Brachytherapy; Clostridioides difficile; Combined Modality Therapy; Complementary Therapies; Enterocolitis, Pseudomembranous; Humans; Immunoglobulins, Intravenous; Metronidazole; Probiotics; Recurrence; Vancomycin

2008
Recurrent cellulitis in a case of Aagenaes syndrome.
    Clinical pediatrics, 2009, Volume: 48, Issue:8

    Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cellulitis; Cholestasis, Intrahepatic; Humans; Ketorolac; Linezolid; Lower Extremity; Lymphedema; Male; Oxazolidinones; Recurrence; Syndrome; Vancomycin

2009
Recurrent and relapsing peritonitis: causative organisms and response to treatment.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 54, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Netilmicin; Peritoneal Dialysis; Peritonitis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2009
Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2009, Volume: 9, Issue:9

    Topics: Arthritis; Drug Hypersensitivity; Eosinophilia; Fas Ligand Protein; Fatal Outcome; Granzymes; Humans; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged; Recurrence; Sulfasalazine; Syndrome; T-Lymphocytes, Cytotoxic; Vancomycin

2009
A refractory case of community-acquired pneumonia.
    The Journal of family practice, 2009, Volume: 58, Issue:11

    Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin

2009
Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheters, Indwelling; Child; Child, Preschool; Coagulase; Disinfection; Female; Humans; Infant; Male; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Treatment Outcome; Vancomycin; Withholding Treatment; Young Adult

2010
Stool transplantation for older patients with Clostridium difficile infection.
    Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drug Administration Schedule; Feces; Humans; Omeprazole; Probiotics; Recurrence; Vancomycin

2009
Repeat 2-stage revision for recurrent infection of total hip arthroplasty.
    The Journal of arthroplasty, 2010, Volume: 25, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Female; Hip Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Recurrence; Reoperation; Tobramycin; Vancomycin

2010
[Effective treatment of recurrent infective endocarditis. Is it always in compliance with the guidelines?].
    Kardiologia polska, 2010, Volume: 68, Issue:2

    Topics: Adult; Aminoglycosides; Aortic Valve; Clindamycin; Endocarditis, Bacterial; Gentamicins; Guideline Adherence; Heart Septal Defects, Ventricular; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Peptides; Recurrence; Staphylococcal Infections; Vancomycin

2010
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:10

    Topics: Adolescent; Ambulatory Care; Anti-Bacterial Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Metronidazole; Microbial Sensitivity Tests; Prevalence; Recurrence; Ribotyping; Rifampin; Severity of Illness Index; Vancomycin

2010
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.
    World journal of gastroenterology, 2010, Jul-28, Volume: 16, Issue:28

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2010
Endogenous endophthalmitis caused by Enterococcus casseliflavus.
    Journal of medical microbiology, 2011, Volume: 60, Issue:Pt 5

    Topics: Anti-Bacterial Agents; Base Sequence; DNA, Bacterial; Endophthalmitis; Enterococcus; Eye Infections, Bacterial; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Recurrence; Vancomycin; Vitrectomy; Young Adult

2011
Coagulase-negative staphylococcal peritonitis: outcomes of cephalosporin-resistant strains.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2010, Volume: 26

    Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalosporin Resistance; Coagulase; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin

2010
Infection of pacemaker lead by penicillin-resistant Streptococcus Pneumoniae.
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2011, Volume: 17, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Device Removal; Drug Administration Schedule; Endocarditis, Bacterial; Humans; Male; Pacemaker, Artificial; Penicillin Resistance; Pneumococcal Infections; Recurrence; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin

2011
Risk factors for recurrence of Clostridium difficile infection: effect of vancomycin-resistant enterococci colonization.
    Journal of Korean medical science, 2011, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Enterococcus; Enterocolitis, Pseudomembranous; Feces; Female; Hemoglobins; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance

2011
Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Genes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Molecular Typing; Recurrence; Risk Factors; Vancomycin; Young Adult

2011
Antimicrobial use and risk for recurrent Clostridium difficile infection.
    The American journal of medicine, 2011, Volume: 124, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Metronidazole; Middle Aged; Minnesota; Recurrence; Retrospective Studies; Risk Factors; Vancomycin

2011
Reinfected revised TKA resolves with an aggressive protocol and antibiotic infusion.
    Clinical orthopaedics and related research, 2012, Volume: 470, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Cohort Studies; Debridement; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Articular; Knee Prosthesis; Male; Middle Aged; Prosthesis-Related Infections; Recovery of Function; Recurrence; Reoperation; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome; Vancomycin

2012
Recognizing metronidazole resistant C. difficile.
    The Nurse practitioner, 2011, Volume: 36, Issue:11

    Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin

2011
Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
    Clinical therapeutics, 2011, Volume: 33, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Daptomycin; Hospital Bed Capacity, 300 to 499; Hospitalization; Hospitals, Private; Humans; Injections, Intravenous; Length of Stay; Medical Records; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Young Adult

2011
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Journal of Korean medical science, 2011, Volume: 26, Issue:10

    Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Female; Hospitals; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Republic of Korea; Treatment Outcome; Vancomycin

2011
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Diarrhea; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome; Vancomycin

2012
High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Teicoplanin; Vancomycin

2012
Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
    International urology and nephrology, 2012, Volume: 44, Issue:5

    Topics: Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefazolin; Ceftazidime; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Enterococcus; Female; Humans; Male; Middle Aged; Multivariate Analysis; Oxacillin; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Streptococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin

2012
Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    The American journal of gastroenterology, 2012, Volume: 107, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colonoscopy; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metagenome; Recurrence; Surveys and Questionnaires; United States; Vancomycin

2012
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
    Military medicine, 2012, Volume: 177, Issue:4

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans

2012
Efficacy of LFF571 in a hamster model of Clostridium difficile infection.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cricetinae; Enterocolitis, Pseudomembranous; Enterotoxins; Male; Mesocricetus; Recurrence; Thiazoles; Vancomycin

2012
Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.
    BMJ case reports, 2011, Nov-21, Volume: 2011

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Humans; Male; Metronidazole; Nitro Compounds; Recurrence; Thiazoles; Vancomycin

2011
Failure mode and effects analysis outputs: are they valid?
    BMC health services research, 2012, Jun-10, Volume: 12

    Topics: Anti-Bacterial Agents; Critical Pathways; Gentamicins; Health Knowledge, Attitudes, Practice; Hospitals, Teaching; Humans; Infusions, Intravenous; Medication Errors; National Health Programs; Patient Care Team; Qualitative Research; Recurrence; Reproducibility of Results; Risk Assessment; Risk Management; Time Factors; Treatment Failure; United Kingdom; Vancomycin

2012
Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.
    Clinical therapeutics, 2012, Volume: 34, Issue:7

    Topics: Anti-Bacterial Agents; Cohort Studies; Daptomycin; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Middle Aged; Osteomyelitis; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

2012
Antimicrobial activities of fidaxomicin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Clostridioides difficile; Clostridium Infections; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Feces; Fidaxomicin; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Recurrence; Vancomycin

2012
Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 55 Suppl 2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Confidence Intervals; Creatine; Fever; Fidaxomicin; Humans; Leukocyte Count; Leukocytosis; Odds Ratio; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; ROC Curve; Severity of Illness Index; Time Factors; Treatment Failure; Vancomycin

2012
Fidaxomicin "chaser" regimen following vancomycin for patients with multiple Clostridium difficile recurrences.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Drug Administration Schedule; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Humans; Male; Recurrence; Treatment Outcome; Vancomycin

2013
Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
    Pharmacotherapy, 2012, Volume: 32, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diagnosis, Differential; Doxycycline; Drug Monitoring; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Staphylococcal Infections; Thrombocytopenia; Vancomycin

2012
Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Alimentary pharmacology & therapeutics, 2013, Volume: 37, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Vancomycin; Young Adult

2013
Pneumatosis intestinalis in a patient with recurrent Clostridium difficile infection.
    BMJ case reports, 2012, Oct-30, Volume: 2012

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colic; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male; Pneumatosis Cystoides Intestinalis; Recurrence; Tomography, X-Ray Computed; Vancomycin

2012
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice.
    PLoS pathogens, 2012, Volume: 8, Issue:10

    Topics: Animals; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Feces; Female; Intestines; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Microbial Consortia; Microbial Interactions; Molecular Sequence Data; Probiotics; Recurrence; Vancomycin

2012
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteroides; Cecum; Clostridioides difficile; Clostridium Infections; DNA, Bacterial; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Intestines; Male; Metronidazole; Mice; Mice, Inbred C57BL; Nitro Compounds; Recurrence; Thiazoles; Treatment Outcome; Vancomycin

2013
Evaluating effectiveness of antibiotic polymethylmethacrylate beads in achieving wound sterilization and graft preservation in patients with early and late vascular graft infections.
    Surgery, 2013, Volume: 153, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antisepsis; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Drug Carriers; Drug Therapy, Combination; Follow-Up Studies; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Limb Salvage; Lower Extremity; Male; Middle Aged; Polymethyl Methacrylate; Prosthesis-Related Infections; Recurrence; Retrospective Studies; Tobramycin; Treatment Outcome; Vancomycin

2013
Recurrent methicillin-resistant Staphylococcus aureus wound ulcer after clear-cornea cataract surgery.
    The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc, 2002, Volume: 28, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Conjunctiva; Corneal Ulcer; Eye Infections, Bacterial; Humans; Lens Implantation, Intraocular; Male; Methicillin Resistance; Phacoemulsification; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps; Surgical Wound Infection; Treatment Outcome; Vancomycin; Visual Acuity

2002
[Endophthalmitis following cataract surgery].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2002, Volume: 99, Issue:12

    Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy

2002
[Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Anales de medicina interna (Madrid, Spain : 1984), 2002, Volume: 19, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colitis, Ulcerative; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Treatment Outcome; Vancomycin

2002
[Antibiotic-associated diarrhea].
    Deutsche medizinische Wochenschrift (1946), 2003, Feb-28, Volume: 128, Issue:9

    Topics: Anti-Bacterial Agents; Diarrhea; Enterocolitis, Pseudomembranous; Fluid Therapy; Humans; Metronidazole; Recurrence; Vancomycin

2003
Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy.
    The American journal of medicine, 2003, Jun-15, Volume: 114, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amputation, Surgical; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Child; Diabetes Complications; Female; Humans; Infusions, Intravenous; Male; Medical Records; Middle Aged; Osteomyelitis; Outcome Assessment, Health Care; Penicillins; Peripheral Vascular Diseases; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Vancomycin; Washington

2003
Valproic acid-induced eosinophilic pleural effusion.
    Southern medical journal, 2003, Volume: 96, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antimanic Agents; Ceftazidime; Chest Pain; Cough; Drainage; Drug Therapy, Combination; Eosinophilia; Eosinophils; Fever; Humans; Leukocyte Count; Male; Pleural Effusion; Recurrence; Schizophrenia; Spinal Puncture; Thoracostomy; Tomography, X-Ray Computed; Valproic Acid; Vancomycin

2003
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
    Archivos de la Sociedad Espanola de Oftalmologia, 2004, Volume: 79, Issue:2

    Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Keratoplasty, Penetrating; Male; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body

2004
Recurrent acute rheumatic fever: a forgotten diagnosis?
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:2

    Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficiency; Arthralgia; Bangladesh; Clarithromycin; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Emigration and Immigration; Endocarditis, Bacterial; England; Female; Fever; Gentamicins; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Penicillin G; Penicillin V; Pericarditis; Pharyngitis; Prednisone; Recurrence; Rheumatic Fever; Rheumatic Heart Disease; Rifampin; Unnecessary Procedures; Vancomycin

2004
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
    Urology, 2004, Volume: 64, Issue:4

    Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; Disease Susceptibility; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hepatitis C; Humans; Male; Methicillin Resistance; Nafcillin; Orchitis; Prostatitis; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Suppuration; Transurethral Resection of Prostate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2004
Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment.
    Reviews in gastroenterological disorders, 2004,Fall, Volume: 4, Issue:4

    Topics: Anti-Bacterial Agents; Diarrhea; Endoscopy, Gastrointestinal; Enterocolitis, Pseudomembranous; Feces; Humans; Immunoenzyme Techniques; Metronidazole; Recurrence; Risk Factors; Vancomycin

2004
Cervical spondylodiscitis from an ingested pin: a case report.
    Journal of pediatric surgery, 2005, Volume: 40, Issue:3

    Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating

2005
Metronidazole for Clostridium difficile-associated disease: is it okay for Mom?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Anti-Bacterial Agents; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2005
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Jun-01, Volume: 40, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Enterocolitis, Pseudomembranous; Humans; Infant; Metronidazole; Middle Aged; Quebec; Recurrence; Risk Factors; Treatment Failure; Vancomycin

2005
The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cloxacillin; Female; Humans; Israel; Male; Methicillin Resistance; Middle Aged; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

2005
Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:6

    Topics: Adult; Aged; Anti-Bacterial Agents; Conjunctivitis, Bacterial; Data Collection; Diabetic Foot; Female; Hospitals, University; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Turkey; Vancomycin

2005
[Relapsing infections with Clostridium difficile].
    Nederlands tijdschrift voor geneeskunde, 2005, Oct-22, Volume: 149, Issue:43

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cytotoxins; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

2005
Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:11-12

    Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Fatal Outcome; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Mitral Valve; Oxazolidinones; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2005
Case of the month. Chronic recurrent multifocal osteomyelitis.
    JAAPA : official journal of the American Academy of Physician Assistants, 2005, Volume: 18, Issue:12

    Topics: Adolescent; Biopsy; Cefepime; Cephalosporins; Chronic Disease; Humans; Humerus; Male; Osteomyelitis; Recurrence; Vancomycin

2005
Wide sleeve resection of lower trachea through anterior approach with omentopexy.
    Asian cardiovascular & thoracic annals, 2006, Volume: 14, Issue:1

    Topics: Adult; Anastomosis, Surgical; Anti-Bacterial Agents; Carcinoma, Adenoid Cystic; Encephalitis, Herpes Simplex; Female; Follow-Up Studies; Humans; Intubation, Intratracheal; Male; Methicillin Resistance; Middle Aged; Omentum; Preoperative Care; Recurrence; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Trachea; Tracheal Neoplasms; Tracheal Stenosis; Vancomycin

2006
Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacteriolysis; Hemolysin Proteins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin; Vancomycin Resistance

2006
Bilateral psoas abscesses post-peripheral blood stem cell transplantation.
    Bone marrow transplantation, 2006, Volume: 38, Issue:1

    Topics: Adult; Cyclosporine; Drainage; Female; Humans; Meropenem; Peripheral Blood Stem Cell Transplantation; Psoas Abscess; Recurrence; Remission Induction; Sensitivity and Specificity; Thienamycins; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin

2006
Two-stage revision of infected total knee replacements using articulating cement spacers and short-term antibiotic therapy.
    The Journal of bone and joint surgery. British volume, 2006, Volume: 88, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bone Cements; Female; Gentamicins; Humans; Knee Joint; Knee Prosthesis; Male; Middle Aged; Predictive Value of Tests; Prosthesis-Related Infections; Range of Motion, Articular; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin

2006
Deep sternal wire infection resulting in severe pulmonary valve endocarditis.
    The Annals of thoracic surgery, 2006, Volume: 82, Issue:3

    Topics: Aged; Bone Wires; Combined Modality Therapy; Coronary Artery Bypass; Debridement; Diagnostic Errors; Endocarditis, Bacterial; Heart Injuries; Heart Ventricles; Humans; Male; Osteitis; Pneumonia; Pulmonary Valve; Pulmonary Valve Insufficiency; Recurrence; Saphenous Vein; Staphylococcal Infections; Sternum; Surgical Wound Dehiscence; Surgical Wound Infection; Suture Techniques; Vancomycin; Ventricular Outflow Obstruction; Wounds, Stab

2006
Reactivation of dormant lumbar methicillin-resistant Staphylococcus aureus osteomyelitis after 12 years.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2007, Volume: 14, Issue:6

    Topics: Abscess; Acetamides; Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Drug Therapy, Combination; Humans; Intervertebral Disc Displacement; Laminectomy; Linezolid; Lumbar Vertebrae; Male; Methicillin Resistance; Osteomyelitis; Oxazolidinones; Recurrence; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Outcome; Vancomycin

2007
[Clostridium difficile associated diarrhea in the elderly patient].
    Revista clinica espanola, 2007, Volume: 207, Issue:2

    Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

2007
A case of recurrent Clostridium difficile diarrhea.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2007, Volume: 22, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin

2007
Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    The American journal of gastroenterology, 2007, Volume: 102, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Chi-Square Distribution; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Metronidazole; Quebec; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Journal of neurosurgery, 2007, Volume: 107, Issue:3 Suppl

    Topics: Adolescent; Anti-Bacterial Agents; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Injections, Intravenous; Injections, Intraventricular; Medical Records; Meningitis; Recurrence; Staphylococcal Infections; Sterilization; Vancomycin

2007
The changing face of Clostridium difficile: what treatment options remain?
    The American journal of gastroenterology, 2007, Volume: 102, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Quebec; Recurrence; Risk Factors; Severity of Illness Index; Treatment Outcome; Vancomycin

2007
Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis.
    Spine, 2007, Oct-15, Volume: 32, Issue:22

    Topics: Aged; Anti-Infective Agents; Discitis; Female; Humans; Leukocyte Count; Male; Methicillin Resistance; Middle Aged; Neurosurgical Procedures; Recurrence; Retrospective Studies; Risk Factors; Sepsis; Sex Distribution; Spine; Staphylococcal Infections; Staphylococcus aureus; Survival Rate; Vancomycin

2007
Pseudomembranous colitis with recurring diarrhoea and prolonged persistence of Clostridium difficile in a 10-year-old girl.
    Acta paediatrica Scandinavica, 1984, Volume: 73, Issue:1

    Topics: Amoxicillin; Carrier State; Child; Clostridium; Clostridium Infections; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Recurrence; Vancomycin

1984
Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Gastroenterology, 1980, Volume: 78, Issue:3

    Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cytotoxins; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Recurrence; Vancomycin

1980
Treatment of recurrent antibiotic-associated pseudomembranous colitis.
    The American journal of gastroenterology, 1982, Volume: 77, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Clostridium Infections; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Male; Middle Aged; Recurrence; Vancomycin

1982
Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease.
    Gastroenterology, 1981, Volume: 80, Issue:4

    Topics: Clostridium; Endotoxins; Feces; Humans; Inflammation; Intestinal Diseases; Recurrence; Vancomycin

1981
Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
    The Netherlands journal of medicine, 1981, Volume: 24, Issue:1

    Topics: Administration, Oral; Aged; Enterocolitis, Pseudomembranous; Humans; Injections, Intravenous; Male; Metronidazole; Recurrence; Vancomycin

1981
A second relapse of Clostridium difficile colitis.
    The Journal of antimicrobial chemotherapy, 1981, Volume: 7, Issue:2

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1981
Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy.
    Archives of internal medicine, 1981, Volume: 141, Issue:5

    Topics: Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Recurrence; Vancomycin

1981
Pseudomembranous colitis: multiple relapses after treatment with metronidazole.
    Canadian Medical Association journal, 1981, Jun-15, Volume: 124, Issue:12

    Topics: Aged; Cholestyramine Resin; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Metronidazole; Recurrence; Vancomycin

1981
Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
    The American journal of medicine, 1981, Volume: 71, Issue:5

    Topics: Adolescent; Adult; Aged; Clostridium Infections; Colitis; Diarrhea; Female; Humans; Infant, Newborn; Male; Middle Aged; Recurrence; Vancomycin

1981
Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin.
    Gastroenterology, 1980, Volume: 78, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Clostridium; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Middle Aged; Recurrence; Vancomycin

1980
Relapse of antibiotic-associated colitis after vancomycin therapy.
    The Medical journal of Australia, 1980, Apr-05, Volume: 1, Issue:7

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
Vancomycin therapy for Clostridium difficile.
    The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2

    Topics: Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Male; Recurrence; Vancomycin

1980
Vancomycin therapy Clostridium difficile.
    The Medical journal of Australia, 1980, Jul-26, Volume: 2, Issue:2

    Topics: Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
Relapse of Clostridium colitis after vancomycin therapy.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:4

    Topics: Adult; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1980
Baker's yeast as adjunctive therapy for relapses of Clostridium difficile diarrhea.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 20, Issue:6

    Topics: Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Recurrence; Saccharomyces cerevisiae; Vancomycin

1995
Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 25, Issue:4

    Topics: Gram-Positive Bacterial Infections; Humans; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin

1995
Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    The Journal of infectious diseases, 1995, Volume: 171, Issue:1

    Topics: Animals; Ceftriaxone; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Penicillins; Rabbits; Random Allocation; Recurrence; Teicoplanin; Vancomycin

1995
Management and control of a large outbreak of diarrhoea due to Clostridium difficile.
    The Journal of hospital infection, 1994, Volume: 27, Issue:1

    Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin

1994
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Contraindications; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; France; Humans; Immunocompromised Host; Leukocyte Count; Mycoses; Neutropenia; Recurrence; Teicoplanin; Time Factors; Vancomycin

1994
[Clostridium difficile in early childhood ulcerative pancolitis].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1993, Volume: 141, Issue:6

    Topics: Biopsy; Colitis, Ulcerative; Enterocolitis, Pseudomembranous; Humans; Infant; Intestinal Mucosa; Male; Prednisone; Recurrence; Sulfasalazine; Vancomycin

1993
[Recurrent abscess of the lung caused by Rhodococcus equi in an HIV-positive patient: response to the combination imipenem/vancomycin].
    Medicina clinica, 1993, May-15, Volume: 100, Issue:19

    Topics: Actinomycetales Infections; Adult; Drug Therapy, Combination; HIV Seropositivity; Humans; Imipenem; Lung Abscess; Male; Recurrence; Rhodococcus equi; Vancomycin

1993
Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis.
    Pediatric nephrology (Berlin, Germany), 1993, Volume: 7, Issue:4

    Topics: Bacteremia; Catheterization, Central Venous; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Heparin; Humans; Kidney Failure, Chronic; Longitudinal Studies; Male; Recurrence; Renal Dialysis; Vancomycin

1993
Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.
    Scandinavian journal of infectious diseases, 1995, Volume: 27, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Male; Methicillin Resistance; Middle Aged; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin

1995
The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    The American surgeon, 1996, Volume: 62, Issue:7

    Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome; Vancomycin

1996
Relapses or reinfections: analysis of a case of Clostridium difficile-associated colitis by two typing systems.
    Current microbiology, 1996, Volume: 33, Issue:4

    Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Female; Humans; Immunoblotting; Recurrence; Vancomycin

1996
Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Leukemia, Promyelocytic, Acute; Male; Recurrence; Vancomycin

1997
Serious infections caused by multiply-resistant Enterococcus faecium.
    Microbial drug resistance (Larchmont, N.Y.), 1995,Fall, Volume: 1, Issue:3

    Topics: Abdomen; Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Liver Transplantation; Male; Recurrence; Sepsis; Vancomycin

1995
Recurrent endophthalmitis after cataract surgery with a scleral-tunnel incision.
    Cornea, 1998, Volume: 17, Issue:2

    Topics: Administration, Topical; Aged; Cataract Extraction; Cefazolin; Cornea; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Injections; Keratitis; Recurrence; Sclera; Staphylococcal Infections; Staphylococcus; Suture Techniques; Vancomycin; Vitreous Body

1998
Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin.
    Lancet (London, England), 1998, Mar-21, Volume: 351, Issue:9106

    Topics: Adult; Anti-Bacterial Agents; Female; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1998
Vancomycin administration in continuous ambulatory peritoneal dialysis: the risk of ototoxicity.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1998, Volume: 118, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Audiometry, Pure-Tone; Auditory Threshold; Caloric Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hearing Loss, Sensorineural; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Vancomycin

1998
Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 1998, Volume: 3, Issue:3

    Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Neoplasms; Chondrosarcoma; Drug Implants; Female; Humans; Male; Methicillin; Methicillin Resistance; Microspheres; Middle Aged; Osteomyelitis; Penicillins; Polymethyl Methacrylate; Radiography; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin

1998
Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Humans; Linear Models; Male; Metronidazole; Prospective Studies; Recurrence; Risk Factors; Serum Albumin; Time Factors; Treatment Failure; Vancomycin

1998
Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy.
    Journal of clinical microbiology, 1999, Volume: 37, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin

1999
A desperate case of failing vascular access--management of superior vena cava thrombosis, recurrent bacteraemia, and acute clavicular osteomyelitis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:2

    Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Clavicle; Equipment Failure; Humans; Male; Osteomyelitis; Phlebography; Recurrence; Renal Dialysis; Tomography, X-Ray Computed; Vancomycin; Venae Cavae; Venous Thrombosis

1999
Treatment of peritonitis in pediatric continuous peritoneal dialysis.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1999, Volume: 19 Suppl 2

    Topics: Anti-Bacterial Agents; Bacterial Infections; Child; Humans; Peritoneal Dialysis; Peritonitis; Recurrence; Staphylococcal Infections; Teicoplanin; Vancomycin

1999
The conservative management of corynebacterium group D2 encrusted pyelitis.
    BJU international, 1999, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Corynebacterium Infections; Humans; Kidney Calculi; Middle Aged; Pyelitis; Recurrence; Therapeutic Irrigation; Tomography, X-Ray Computed; Vancomycin

1999
Treatment strategies for postoperative Propionibacterium acnes endophthalmitis.
    Ophthalmology, 1999, Volume: 106, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Combined Modality Therapy; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Male; Middle Aged; Propionibacterium acnes; Recurrence; Reoperation; Retrospective Studies; Vancomycin; Visual Acuity; Vitrectomy

1999
Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Bacteriolysis; Cephalosporins; Female; Head; Humans; Infant; Magnetic Resonance Imaging; Meningitis, Pneumococcal; Recurrence; Spine; Tomography; Vancomycin; Vancomycin Resistance

2000
Epidemic Bacillus endophthalmitis after cataract surgery II: chronic and recurrent presentation and outcome.
    Ophthalmology, 2000, Volume: 107, Issue:6

    Topics: Aged; Aged, 80 and over; Anterior Chamber; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus; Chronic Disease; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body

2000
[Recurrent Clostridium difficile enterocolitis].
    Schweizerische medizinische Wochenschrift, 2000, Nov-04, Volume: 130, Issue:44

    Topics: Aged; Aged, 80 and over; Clostridioides difficile; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Immunoglobulins, Intravenous; Metronidazole; Recurrence; Saccharomyces; Vancomycin

2000
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:1

    Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin

2001
Infection of central nervous system by motile Enterococcus: first case report.
    Journal of clinical microbiology, 2001, Volume: 39, Issue:2

    Topics: Aged; Central Nervous System Bacterial Infections; Drug Therapy, Combination; Enterococcus; Fever; Gentamicins; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Male; Meningitis; Microbial Sensitivity Tests; Recurrence; Vancomycin; Ventriculoperitoneal Shunt

2001
Liver abscess caused by Clostridium difficile.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Drainage; Female; Humans; Liver Abscess; Metronidazole; Recurrence; Treatment Failure; Vancomycin

2001
Prophylaxis against staphylococcal infection before tertiary knee joint replacement.
    Orthopedics, 2001, Volume: 24, Issue:3

    Topics: Antibiotic Prophylaxis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Knee Joint; Middle Aged; Preoperative Care; Prosthesis Failure; Prosthesis-Related Infections; Recurrence; Reoperation; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin

2001
Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty.
    The Journal of arthroplasty, 2001, Volume: 16, Issue:7

    Topics: Adult; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Cefotaxime; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Treatment Outcome; Vancomycin

2001
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin

2002
Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening.
    Journal of pediatric gastroenterology and nutrition, 2002, Volume: 34, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Clostridioides difficile; Colon; Cystic Fibrosis; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Feces; Humans; Male; Metronidazole; Recurrence; Tomography, X-Ray Computed; Ultrasonography; Vancomycin

2002
Relapse of pseudomembranous colitis after vancomycin therapy.
    Lancet (London, England), 1979, Nov-17, Volume: 2, Issue:8151

    Topics: Administration, Oral; Aged; Clostridium Infections; Enterocolitis, Pseudomembranous; Female; Humans; Recurrence; Vancomycin

1979
Single-antibiotic therapy for streptococcal endocarditis.
    JAMA, 1979, Apr-27, Volume: 241, Issue:17

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalothin; Child; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Humans; Infusions, Parenteral; Injections, Intramuscular; Middle Aged; Penicillin G; Penicillin G Procaine; Penicillin V; Recurrence; Streptococcal Infections; Streptococcus; Vancomycin

1979
Relapse of pseudomembranous colitis after vancomycin therapy.
    The New England journal of medicine, 1979, Aug-23, Volume: 301, Issue:8

    Topics: Administration, Oral; Adult; Aged; Clostridium; Clostridium Infections; Enterocolitis, Pseudomembranous; Feces; Humans; Recurrence; Time Factors; Vancomycin

1979
Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1992, Volume: 8

    Topics: Adolescent; Cefotaxime; Child; Child, Preschool; Drug Therapy, Combination; Fosfomycin; Humans; Infant; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Recurrence; Thrombolytic Therapy; Urokinase-Type Plasminogen Activator; Vancomycin

1992
Medical cure of a brainstem abscess and serial brainstem auditory evoked potentials.
    Developmental medicine and child neurology, 1992, Volume: 34, Issue:10

    Topics: Brain Abscess; Brain Stem; Child; Chloramphenicol; Drug Therapy, Combination; Evoked Potentials, Auditory, Brain Stem; Female; Humans; Reaction Time; Recurrence; Tomography, X-Ray Computed; Vancomycin

1992
Long-term, intraperitoneal vancomycin in the prevention of recurrent peritonitis during CAPD: preliminary results.
    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 1991, Volume: 11, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Humans; Infusions, Parenteral; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Time Factors; Vancomycin

1991
Delayed-onset pseudophakic endophthalmitis.
    American journal of ophthalmology, 1991, May-15, Volume: 111, Issue:5

    Topics: Cataract Extraction; Endophthalmitis; Eye Infections, Bacterial; Humans; Lenses, Intraocular; Prednisolone; Propionibacterium acnes; Recurrence; Vancomycin; Vitrectomy

1991
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:6

    Topics: Adult; Endocarditis, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Recurrence; Staphylococcal Infections; Substance Abuse, Intravenous; Vancomycin

1990
Urokinase: a treatment for relapsing peritonitis due to coagulase-negative staphylococci.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1989, Volume: 4, Issue:1

    Topics: Bacterial Typing Techniques; Drug Therapy, Combination; Follow-Up Studies; Humans; Length of Stay; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Urokinase-Type Plasminogen Activator; Vancomycin

1989
Multiple relapses of Clostridium difficile-associated diarrhea responding to an extended course of cholestyramine.
    The Pediatric infectious disease journal, 1989, Volume: 8, Issue:3

    Topics: Bacterial Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Diarrhea, Infantile; Drug Therapy, Combination; Enterotoxins; Female; Humans; Infant; Male; Recurrence; Vancomycin

1989
Peritonitis in continuous ambulatory peritoneal dialysis patients in southern Israel.
    Israel journal of medical sciences, 1989, Volume: 25, Issue:12

    Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefazolin; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recurrence; Risk Factors; Vancomycin

1989
Treatment of Clostridium difficile diarrhea.
    The Medical letter on drugs and therapeutics, 1989, Oct-20, Volume: 31, Issue:803

    Topics: Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin

1989
Rhodococcus peritonitis in a patient treated with peritoneal dialysis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1989, Volume: 14, Issue:5

    Topics: Actinomycetales Infections; Cefazolin; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Recurrence; Rhodococcus; Vancomycin

1989
Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.
    Archives of internal medicine, 1989, Volume: 149, Issue:3

    Topics: Anti-Bacterial Agents; Catheterization; Cephalothin; Cross Infection; Endocarditis, Bacterial; Follow-Up Studies; Humans; Oxacillin; Prospective Studies; Recurrence; Risk Factors; Sepsis; Staphylococcal Infections; Time Factors; Vancomycin

1989
Enterococcal osteomyelitis in the diabetic patient.
    Journal of the American Podiatric Medical Association, 1986, Volume: 76, Issue:1

    Topics: Diabetes Complications; Drug Resistance, Microbial; Enterococcus faecalis; Foot Diseases; Humans; Male; Middle Aged; Osteomyelitis; Recurrence; Streptococcal Infections; Vancomycin

1986
Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy.
    Annals of internal medicine, 1988, Oct-15, Volume: 109, Issue:8

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Nafcillin; Recurrence; Sepsis; Staphylococcal Infections; Substance-Related Disorders; Tobramycin; Vancomycin

1988
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:1

    Topics: Animals; Bacterial Proteins; Bacterial Toxins; Clostridium; Cricetinae; Disease Models, Animal; Enterocolitis, Pseudomembranous; Latex Fixation Tests; Recurrence; Saccharomyces; Vancomycin

1987
Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain.
    European journal of clinical microbiology, 1987, Volume: 6, Issue:1

    Topics: Aged; Aged, 80 and over; Clostridium; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Recurrence; Vancomycin

1987
Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin.
    Journal of clinical gastroenterology, 1987, Volume: 9, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Clostridium; Clostridium Infections; Colitis; Diarrhea; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Rifampin; Vancomycin

1987
Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis.
    The British journal of surgery, 1986, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacitracin; Bacterial Toxins; Child; Child, Preschool; Clostridium; Enterocolitis, Pseudomembranous; Female; Humans; Infant; Male; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Vancomycin

1986
Antibiotic-associated colitis: why do patients relapse?
    Gastroenterology, 1986, Volume: 90, Issue:4

    Topics: Bacitracin; Colitis; Humans; Metronidazole; Recurrence; Vancomycin

1986
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis.
    The American journal of gastroenterology, 1985, Volume: 80, Issue:11

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridium; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Middle Aged; Recurrence; Spores, Bacterial; Vancomycin

1985
Clinical value of antistaphylococcal drugs.
    Contributions to microbiology and immunology, 1973, Volume: 1

    Topics: Acute Disease; Anti-Infective Agents; Cephalosporins; Chronic Disease; Czechoslovakia; Drug Evaluation; Endocarditis, Bacterial; Erythromycin; Fusidic Acid; Gentamicins; Humans; Lincomycin; Novobiocin; Osteomyelitis; Penicillins; Recurrence; Rifamycins; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Vancomycin

1973